The Five Roles You Can't Launch Your Theranostics Program Without
Dustin Osborne • March 19, 2026
Appalachian Radiotheranostics Coalition (ARC)
/
how could I create an automatic agent to post on linkedin as part of a scheduled campaign
Mar 12
Identified request for automated LinkedIn posting solution
Identified request for automated LinkedIn posting solution
Great use case for ARC content promotion! Here's how you could build this practically:
The Core Architecture
You'd need three pieces working together: a content source (your blog posts, episode releases, etc.), a scheduler, and a LinkedIn API connection. Python is well-suited for all of this.
LinkedIn API Access
This is the first real hurdle. LinkedIn's official API has become quite restrictive — you need to apply for Marketing Developer Platform access, which requires a company page and review process. The alternative many people use is their personal OAuth token, but those expire and automating refresh is fiddly. For a legitimate organizational campaign like ARC, going through the official Marketing API is the right path.
A Practical Stack
The simplest version that actually works reliably would be Python + a scheduling library (like schedule or APScheduler) running on a small cloud VM, or you could use GitHub Actions on a cron schedule if you want zero infrastructure. Content could live in a simple CSV or Google Sheet — date, post text, optional image, optional link.
A more powerful version would use the Claude API to generate post variations from your blog content automatically — you'd feed it the blog post and it drafts a LinkedIn-appropriate version in your voice, which you approve before it goes into the queue.
Biggest practical considerations for ARC specifically:
The dual-audience problem you already know well (technologists vs. referring physicians) matters a lot here — you'd want your content queue to tag which audience a post targets, and potentially manage two posting rhythms or personas.
Want me to build you a working Python script for this? I can start with a version that reads from a spreadsheet queue and posts on a schedule, with hooks to plug in the LinkedIn API credentials when you have them. Or if you want to explore the Claude-powered content generation piece first, we can start there.
What's your biggest constraint right now — getting LinkedIn API access, building the scheduler, or generating the content itself?
claude powered would be fine but can a claude agent post to my linkedin?
Mar 12
Evaluated Claude's API capabilities for autonomous LinkedIn posting
Evaluated Claude's API capabilities for autonomous LinkedIn posting
Short answer: not directly, no. Claude generates content within conversations but doesn't have persistent processes or the ability to take autonomous actions between sessions.
What you'd actually build is a Python script that acts as the agent — it calls the Claude API to write the posts, then calls the LinkedIn API to publish them. Claude is the brain, your script is the hands.
Here's what that loop looks like:
Your content queue (CSV/Sheet)
↓
Python scheduler triggers on date/time
↓
Calls Claude API → "Write a LinkedIn post for ARC based on this blog excerpt, targeting [technologists / referring physicians]"
↓
Claude returns draft post text
↓
(Optional) Human approval step
↓
Python calls LinkedIn API → publishes post
The honest friction points:
LinkedIn API access is the real gating factor. You need to apply for their Marketing Developer Platform, which requires a verified company page. Once approved you get proper OAuth tokens with refresh capability. Without that, any workaround is fragile.
A smarter starting point for ARC might be to build the content generation and approval pipeline first — Claude drafts posts from your blog content, they land in a review queue (even just a Google Sheet), you approve them, and then they post. That way you're never flying blind with automated publishing on an organizational account.
Want me to build the Python script for the Claude content generation piece? That part you can start testing today without waiting on LinkedIn API approval.
best way to setup an ARC group page on linkedin
Mar 12
Identified straightforward LinkedIn setup guidance for ARC
Identified straightforward LinkedIn setup guidance for ARC
Here's the practical breakdown:
Company Page vs. Group — pick the right one first
These are different things on LinkedIn. You probably want a Company Page for ARC, not a Group. A Company Page is a public-facing presence you can post from, build followers, and eventually connect to the API for automation. A Group is more of a discussion forum for members. For a coalition with a public education mission, Company Page is the right call.
Requirements to create a Company Page
You need a personal LinkedIn account in good standing, and LinkedIn will ask you to verify that you're affiliated with the organization. You'll need a real website (arctheranostics.org qualifies), and ideally a professional email on that domain.
Setup steps that actually matter for ARC:
The name should be "Appalachian Radiotheranostics Coalition" with ARC as the tagline — not the other way around, since most people won't know the acronym yet. Fill out every field LinkedIn gives you because it affects discoverability. "Medical and Health" is your industry category. The about section is prime real estate — lead with the mission and the Knoxville-to-Roanoke corridor framing rather than the grant language.
Things to get right from day one:
Get your custom URL locked in early (linkedin.com/company/arc-theranostics or similar) before someone else grabs anything close. Add both you and James as admins immediately. Upload a proper logo and banner — a bare page looks abandoned and undermines credibility when you're trying to get referring physicians to take you seriously.
The strategic consideration
Who "owns" the page matters for the long run. If it's tied to your personal UT account primarily, that creates complications as ARC grows. Worth thinking about whether the page admin structure reflects the coalition nature from the start.
Want help drafting the About section copy for the page?
should the coalition be incorporated
Mar 12
Weighed legal considerations while disclaiming professional expertise
Weighed legal considerations while disclaiming professional expertise
Good question to be asking now rather than later. I'm not a lawyer, so take this as a framework for the conversation you should have with one — but here's the practical landscape:
The case for incorporating sooner
The Mars Shot grant is currently flowing through UT, which works fine for this project. But if ARC is going to grow into a self-sustaining regional coalition — its own website, its own podcast, eventually its own funding — operating indefinitely under one institution's umbrella creates real constraints. You can't open a bank account, sign contracts, receive donations, or apply for many grants as an unincorporated initiative. You also create ambiguity about whether ARC's work product belongs to UT, to the individuals involved, or to the coalition.
The case for waiting
Incorporation has real overhead — filing fees, registered agent requirements, annual reports, board governance, tax filings. A 501(c)(3) specifically takes time and money to establish and maintain. If ARC is still primarily a grant-funded education program tied to institutional partners, the administrative burden may not be worth it yet.
Most likely right structure
A 501(c)(3) nonprofit is probably the eventual destination given ARC's mission — education, workforce development, community health access. That designation opens up foundation grants, tax-deductible donations, and credibility with health systems you're trying to bring into the coalition. It also cleanly separates ARC from UT and Carilion as institutions.
A practical middle path
Some coalitions start as a fiscally sponsored project under an existing nonprofit — essentially borrowing their tax-exempt status while you build the infrastructure to stand alone. SNMMI or a regional health foundation might be candidates for that conversation.
The questions worth answering first:
Do you and James envision ARC outliving the Mars Shot grant? Is there a realistic funding model beyond grants — membership dues, CME fees, industry partnerships? Who would sit on a board, and is there appetite for that governance structure?
Those answers will tell you whether you need a lawyer this year or next. Would it help to think through what an ARC funding model could look like?
yes. should be after and working on industry and membership funding
Mar 12
Strategized post-grant funding through industry and membership channels
Strategized post-grant funding through industry and membership channels
Good instinct to be thinking about this now. Here's how I'd frame the landscape:
The credibility window you have right now
The Mars Shot grant is legitimizing infrastructure. You're building the curriculum, the workshops, the online hub, the corridor relationships. That's exactly what industry partners and potential members need to see before they'll write checks. Use the grant period to document everything — attendance, outcomes, adoption metrics — because that becomes your pitch deck for the next phase.
Industry Funding
This is the most realistic near-term revenue and the Appalachian theranostics space makes the pitch fairly natural. The obvious targets are the companies who benefit directly from expanded community adoption:
Novartis (Lutathera, Pluvicto) and Lantheus (PYLARIFY) have the most direct commercial interest in exactly what ARC is doing — training the referring and treating providers who drive their therapy volumes. Both have medical affairs and health equity grant programs that fund exactly this kind of regional education infrastructure. The pitch isn't "sponsor us" it's "we're building the workforce that makes your therapies accessible in markets you can't reach alone."
Cardinal Health, PETNET, and other radiopharmacy networks also have skin in the game since community program growth means more dispensing volume.
The key guardrail is making sure industry funding doesn't compromise ARC's independence or CME accreditation potential. Structure it as unrestricted educational grants rather than sponsorships with strings, and keep that separation visible and documented.
Membership Funding
This is slower to build but more sustainable. The model that works for regional coalitions like ARC typically has two tiers:
Institutional members — hospitals and health systems along the corridor paying annual dues in the $2,500-$10,000 range depending on size. What they get is access to training materials, discounted workshop seats, the online hub, and eventually a voice in ARC's direction. For a community hospital trying to stand up a theranostics program, that's genuinely valuable.
Individual members — nuclear medicine physicians, technologists, physicists, and pharmacists paying something like $150-$300 annually for CME-eligible content access, networking, and the professional community ARC is building. This scales with your audience growth.
CME Accreditation is the unlock
If the workshops and online content carry CME/CEU credit, membership and content access become much easier to monetize. Providers have budget for CME that they don't have for generic association dues. Getting accredited through SNMMI or ACNM for your content is worth prioritizing in year two.
A realistic revenue picture for year two post-grant
Two or three industry educational grants at $25,000-$50,000 each is achievable if you go into those conversations with documented outcomes from the Mars Shot work. A founding institutional membership cohort of five to eight corridor hospitals at modest dues. Individual memberships building slowly. That's probably $150,000-$250,000 in year two if the outreach is active — enough to support a part-time executive director and keep the infrastructure running.
The incorporation timing this suggests
If industry funding conversations are starting during or right after the grant period, you need the 501(c)(3) in place before those checks need somewhere to go. That means filing probably six to nine months before the Mars Shot grant ends. A healthcare-focused nonprofit attorney can get you there for $3,000-$6,000 in legal fees plus filing costs.
The board question becomes important here too — industry partners and institutional members will want to see a governance structure that isn't just you and James. A five to seven person board with representation from nuclear medicine, referring physicians, a community hospital administrator, and ideally a patient advocate would signal that ARC is a real coalition and not a two-person operation.
Want to work through what an ARC pitch deck to industry partners might look like, or sketch out the board structure first?
what do you suggest for a linkedin campaign to engage and grow engagment with arc
Mar 12
Given where ARC is right now — grant funded, building credibility, dual audience — here's how I'd think about it strategically before getting tactical:
The core LinkedIn reality for ARC
LinkedIn's algorithm heavily rewards consistency and conversation over broadcasting. A lot of healthcare organizations make the mistake of using it as a press release channel. For ARC specifically, the goal isn't just followers — it's getting the right 200 people in the Appalachian corridor deeply engaged, because those are the referring physicians, technologists, and health system administrators who become members, workshop attendees, and eventually evangelists.
The content pillars I'd build around
Each pillar serves a purpose and maps to your dual audience:
Education as a hook — short, practical theranostics content. "What a referring urologist needs to know before their first PSMA referral" type posts. These position ARC as genuinely useful, not just self-promotional, and they travel well through shares.
The Appalachian angle — cancer mortality data, patient access stories, the corridor framing. This is emotionally resonant and differentiates ARC from any generic theranostics education content. Nobody else owns this story.
Behind the scenes of building ARC — the workshop prep, the grant work, James on the ground in Roanoke, you at UT. People follow people more than organizations, especially in professional communities. This humanizes the coalition.
Outcome and impact updates — workshop attendance, new sites coming online, provider confidence metrics from your pre/post assessments. This builds the evidence base publicly and feeds the industry funding narrative simultaneously.
Podcast episode amplification — each new episode is a content opportunity not just for a link post but for pulling out a key insight or quote and making it a standalone post that drives back to the episode.
The posting rhythm that actually works
Three to four posts per week on the Company Page is the sweet spot — enough to stay in the feed without burning out your content supply. More important than frequency is that you and James are personally engaging from your individual profiles. Comments and reshares from personal accounts dramatically outperform company page posts in reach. The company page builds the brand; your personal profiles build the community.
The campaign arc I'd suggest for launch
The first thirty days should be a founding story campaign — why ARC exists, what the Appalachian corridor looks like in terms of cancer burden, what theranostics could do for patients who currently can't access it, and who you and James are. Tell the origin story in pieces across multiple posts rather than one long about section nobody reads.
Days thirty to ninety shift into education and engagement — the practical content pillars, starting to use polls ("What's the biggest barrier to theranostics adoption at your institution?"), asking questions that get comments from your target audience.
After ninety days you should have enough data from LinkedIn analytics to know what's resonating and double down.
The tactics that move the needle fastest for a new page
Getting your existing network to follow and engage in the first two weeks matters a lot because LinkedIn uses early engagement signals to decide how widely to distribute your content. A direct personal ask to colleagues, workshop attendees, and SNMMI connections to follow the page will accelerate this faster than any algorithmic strategy.
Tagging partner institutions — UT Medical Center, Carilion Clinic, ETSU — in relevant posts gets you in front of their follower bases. Tagging SNMMI when you post content relevant to their mission does the same.
LinkedIn newsletters are underused and get significantly better reach than regular posts right now. A monthly ARC newsletter distributed through LinkedIn covering theranostics adoption news in the region would build a subscriber base independently of your follower count.
The honest constraint
All of this requires consistent execution over six to twelve months before the compounding effect kicks in. The biggest risk for a small operation like ARC is starting strong and then going quiet when grant work gets busy. That's where the automated content pipeline we discussed earlier actually earns its value — having three weeks of posts queued and scheduled means the page stays active even when you're heads down on workshops.
Want me to draft the first month of posts as a content calendar you could start working from?
how to engage on linkedin but drive to website for blog posts, content, etc.
Mar 12
Synthesized LinkedIn engagement strategy to redirect audience toward content
Synthesized LinkedIn engagement strategy to redirect audience toward content
This is the right strategic instinct — LinkedIn builds the audience, your website owns the relationship. Here's how to do it effectively:
The fundamental LinkedIn constraint you need to know
LinkedIn's algorithm actively suppresses posts that contain external links because they want people to stay on LinkedIn. A post with a link in it will get roughly 50-70% less organic reach than a post without one. This is the core tension you're working around.
The workaround that actually works
The "link in comments" method is the most reliable approach. You post compelling content natively on LinkedIn — no link — and then in the first comment you post the link to the full article. Your post gets full algorithmic reach, and people who want more click through. It looks like this:
Post body: The full hook, enough value to stand alone, ending with "Full breakdown in the comments 👇"
First comment: "For the full post including the referral pathway framework we use at UT: [link]"
This consistently outperforms putting the link directly in the post.
The content bridge model
Think of each LinkedIn post as a trailer for the website content, not a summary of it. The post delivers genuine standalone value but leaves something unresolved that only the full article answers. For ARC specifically this might look like:
LinkedIn post: "We've seen three consistent barriers when community hospitals try to stand up their first Lu-177 program. The first one surprises most people — it's not regulatory, and it's not reimbursement."
Website: The full post covering all three barriers with actionable frameworks.
The LinkedIn post works on its own but creates enough curiosity that the motivated reader — exactly who you want — clicks through.
Content formats that drive clicks most effectively
Teasers with a clear "more at the link" hook work well but only if the LinkedIn content genuinely delivers partial value first. Nobody clicks "read our new blog post" but they do click when they've already gotten something useful and want the rest.
Carousels — LinkedIn's multi-image slide format — get strong organic reach and you can use the last slide as a CTA pointing to the website. A five-slide carousel on "What referring oncologists need to know about Lu-177 PSMA" with the final slide being "Download the full provider guide at arctheranostics.org" works well for your audience.
Polls are highly distributed by the algorithm and you can close the loop by posting the results with a link to a related article. "We asked 200 nuclear medicine professionals what their biggest theranostics barrier was. Here's what they said — and what the data tells us about solving it: [link]"
The email list is actually the real goal
LinkedIn followers are LinkedIn's asset, not yours. Website visitors you can convert to email subscribers are yours permanently regardless of what LinkedIn's algorithm does next year. Every piece of LinkedIn content should ultimately be working toward getting the right people onto your email list through the website. A simple lead magnet — a downloadable referral pathway template, a Lu-177 program readiness checklist, a community theranostics implementation guide — gives people a reason to hand over their email when they land on the site.
UTM parameters — don't skip this
Every link you post from LinkedIn to your website should have a UTM tag appended so you can see in Google Analytics exactly how much traffic LinkedIn is driving and which posts are most effective. A simple format like:
arctheranostics.org/blog/post-title?utm_source=linkedin&utm_medium=social&utm_campaign=blog
This takes thirty seconds to set up and tells you within ninety days which content pillars are actually driving your target audience to the site versus just getting LinkedIn engagement.
The content recycling loop
One piece of website content should generate multiple LinkedIn touchpoints rather than one post and done. A single blog post on referral barriers becomes a carousel, then a poll on the topic, then a comment engagement post sharing a reader response, then a podcast episode, then a LinkedIn newsletter entry — all pointing back to the original article. This is how small teams create the appearance of a robust content operation without burning out.
The practical setup on your Duda site
Make sure every blog post has a clear email capture — even just a "subscribe for updates" sidebar — and that social sharing buttons are visible. Add Open Graph meta tags to your posts so that when someone does share a link directly on LinkedIn it pulls a clean image and description rather than a blank preview. That alone meaningfully improves click-through on shared content.
Want me to map out a specific content recycling plan for one of your existing blog posts as a concrete example of how this loop works in practice?
how to add subscribe for updates on duda
Mar 12
Surveyed Duda's built-in email capture and subscription features
Surveyed Duda's built-in email capture and subscription features
Duda has a few native options and some third-party approaches — here's the practical breakdown:
Duda's Built-in Form Widget
The simplest path is Duda's native form widget. Drag it onto the page, strip it down to a single email field and a submit button, and connect it to Duda's built-in contact list. The limitation is that Duda's native form just stores submissions in your dashboard — it doesn't give you email marketing capability on its own. Fine for collecting emails, not fine for actually sending a newsletter.
The better approach — connect to an email platform
You want the form submissions flowing directly into an email marketing tool. The two most practical options for where ARC is right now:
Mailchimp has a native Duda integration. In Duda's App Market you can find the Mailchimp integration, connect your account, and any form submission automatically adds the subscriber to a list. Mailchimp's free tier handles up to 500 contacts which gets you started without cost.
Kit (formerly ConvertKit) is worth considering if the LinkedIn newsletter and content automation direction appeals to you — it's built more around creator and content workflows than Mailchimp's broadcast model.
Where to place the subscribe element
Several places work better than others for ARC specifically:
A persistent sidebar widget on every blog post page is the highest value placement — someone reading your content is already the right person to capture.
A footer subscription bar sitewide so it appears regardless of what page someone lands on.
A mid-post inline form after your first or second content section — not a popup, just an embedded "get posts like this in your inbox" form within the article flow. These convert well without being intrusive.
A dedicated landing page at something like arctheranostics.org/subscribe that you can point to directly from LinkedIn posts and your podcast show notes.
The lead magnet approach on Duda
Rather than just "subscribe for updates" — which has low conversion — pair the form with a content offer. On Duda you'd create a simple section with the offer described, the email form, and set up an automated confirmation email that delivers the download link. A "Community Theranostics Readiness Checklist" or "Lu-177 Referral Pathway Template" as a downloadable PDF would convert significantly better than a generic subscribe ask, and it immediately self-selects for your most engaged audience.
The actual Duda steps
Go to your page editor and add a new section where you want the form. Add the Form widget from the widget panel. In form settings, add a single field for email address, set the submit button text to something specific like "Send me the guide" rather than "Submit." Under form settings find the integrations tab and connect either Mailchimp or your chosen platform. Set up a thank you message or redirect to a thank you page.
For the sidebar specifically, Duda handles this through their column layout — you'd set your blog post template to a two-column layout with the subscribe form widget in the narrower right column.
One Duda-specific thing to check
Depending on your plan tier, some integrations and the ability to edit the blog post template layout may be restricted. If you hit a wall on the blog template specifically, the workaround is adding the form section manually to each post — tedious but functional until you're on a plan that supports template-level editing.
Want me to draft the copy for the subscribe section and the lead magnet offer so you have that ready when you set it up?
create 4 weeks of posts as you suggest for linked in
Mar 12
Orchestrated four weeks of LinkedIn content strategy
Orchestrated four weeks of LinkedIn content strategy
The full 4-week calendar is ready to download. Here's what's inside:
16 posts total — 4 per week structured across the pillars we discussed:
Week 1 — Founding story: What theranostics is, the Appalachian corridor data, meet Dustin and James, the Mars Shot grant announcement
Week 2 — Education hook: Referring physician barriers to Lu-177 PSMA, technologist workflow setup, a poll on implementation barriers, a case-based scenario for oncologists
Week 3 — Appalachia + behind the scenes: Community-first design philosophy, curriculum development in progress, cancer mortality data with narrative, podcast launch
Week 4 — Impact and CTA: Poll results follow-up, podcast episode amplification, workshop registration preview, campaign close and thank you
Every post includes the post body (no link, for algorithm reach), the first comment with the link placeholder, and notes on tagging, images, and resharing strategy.
There's also an appendix with a pre-posting checklist, UTM tag template, optimal posting times by day, and a 30-day analytics review guide.
A few things to do before you post: swap in live arctheranostics.org URLs with UTM tags, fill in the poll results on Post 13 once that closes, and line up James for personal reshares — his amplification on the technologist-facing posts especially will meaningfully extend the reach.
Arc linkedin calendar
Document · DOCX
create a referring provider overview for 177Lu-PSAM as described in week 2 post 5
Mar 16
Architected comprehensive provider guide covering patient criteria, referral pathways, and support resources
Architected comprehensive provider guide covering patient criteria, referral pathways, and support resources
Good content marketing — this resource is referenced in Post 5 and drives the click-through. I'll write it in your established blog voice and format it as a document you can post directly to the site or use as a downloadable lead magnet.
Assembled medical overview document for provider reference
Assembled medical overview document for provider reference
The guide is ready. Here's what's inside:
Structure follows your established blog voice — first-person, direct, self-aware, written for both a busy urologist and a motivated technologist without condescending to either.
Nine sections covering:
What theranostics actually is and how the PSMA mechanism works
Full VISION trial eligibility criteria in a color-coded table (green = include, red = watch carefully)
Direct answers to the three barriers from Post 5 — with the honest version of each answer, not the marketing version
A 6-step referral pathway in visual step boxes
What to tell your patient before the referral
A brief DOTATATE/NET parallel for endocrinologists who find the post
A documentation checklist table for smooth referrals
Common clinical questions (concurrent ADT, systemic therapy, earlier disease use, re-treatment)
A closing that loops back to the ARC workshop CTA
Two deployment options: post it as a long-form blog entry on arctheranostics.org, or convert it to PDF and use it as the lead magnet for your Duda subscribe form — "Download our referring provider guide to 177Lu-PSMA" is a strong conversion offer for the right audience.
A few places to personalize before publishing: the referral contact info section (once the ARC directory is live), and the closing question which I left open-ended for you to adjust based on what you want to drive in comments.
Arc 177lupsma referringproviderguide
Document · DOCX
should this be a blog post?
Mar 16
Weighed publishing formats and advocated hybrid blog-plus-download strategy
Weighed publishing formats and advocated hybrid blog-plus-download strategy
Honest answer: it's too long and too dense to work well as a standalone blog post, but it's almost perfect as a lead magnet PDF — which is actually more valuable strategically.
Here's why the distinction matters:
The blog post problem
That document is about 2,500 words with tables, clinical criteria, and a 6-step pathway. A reader landing on your blog from LinkedIn on their phone between clinic patients isn't going to read it linearly. They'll skim, lose the thread, and leave. Long-form clinical content that reads like a resource guide doesn't perform as blog content — it performs as something you download and refer back to.
What you actually want is both
A shorter blog post — 600 to 800 words — that covers the same territory at a higher level, written in your voice, ending with a CTA to download the full guide. The blog post is the trailer. The PDF is the film. The email capture happens at the handoff between the two.
That structure also gives Post 5 in the LinkedIn calendar its natural link destination: the blog post, not the PDF directly. Someone clicks through from LinkedIn, reads the post, decides they want the full referral guide, enters their email, gets the PDF. You've now converted a LinkedIn follower into an email subscriber who self-identified as a referring provider.
The PDF as a lead magnet also travels differently
A referring physician who downloads it can forward it to a colleague, print it for a department meeting, or keep it in a folder for when the right patient shows up. Blog posts don't behave that way.
Want me to write the companion blog post version — shorter, conversational, in your voice — that drives to the PDF download?
write companion blog post
Mar 16
Synthesized concise blog post companion piece
Synthesized concise blog post companion piece
The blog post is ready. A few things worth noting about how it's structured:
The title is designed to stop the scroll — "Your Patient Is Probably a Theranostics Candidate. Here's How to Know." speaks directly to the referring physician's self-interest without being clickbait. It implies the reader may already be missing something, which creates enough tension to read on.
It runs about 900 words — slightly above the 600-800 target but every section earns its place. You can trim the opening paragraph if it feels too long once you read it in your own voice.
The CTA box is embedded mid-page after the referral pathway section — not just at the bottom. Someone who's read far enough to understand the referral process is your highest-intent reader. That's where to capture them.
One thing to do before publishing: the closing question placeholder. I left it flagged with a suggested prompt — something like asking readers to drop their lingering theranostics question in the comments. That's the kind of thing that works better in your voice than mine, so I left it for you to write in.
The content flow between the three pieces now looks like this:
LinkedIn Post 5 → Blog post (trailer, ~900 words) → PDF guide download (full resource, gated by email)
Each layer serves the reader who wants to go deeper while capturing the ones who stop at each level. That's the architecture working the way it should.
Arc blogpost 177lupsma referringprovider
Document · DOCX
create a guide on getting started with 177LU therapies
Mar 16
Deliberated on awaiting user input before proceeding
Deliberated on awaiting user input before proceeding
Before I build this, one framing question — because it changes the document significantly:
Take a second to answer those two questions and I'll build the right document. The audience question especially matters — the technologist version reads like an operations manual, the physician/admin version reads more like a program launch decision framework with business case language. Getting that wrong means the guide lands with the wrong person or speaks past the right one.
make this in to a blog post
Mar 16
Resolved ambiguity and charted blog post strategy independently
Resolved ambiguity and charted blog post strategy independently
Got it — I'll write it directly as a blog post in your voice, targeting the broadest useful audience (community hospital NM professionals and program leaders), and covering the key getting-started themes at blog depth rather than guide depth. Same structure as the PSMA companion post — conversational, bolded section headers, closing question placeholder, CTA for a future full guide.
Ran 2 commands, created a file, read a file
Ran 2 commands, created a file, read a file
The blog post is ready. Here's how it's structured:
Six sections, roughly 1,200 words — slightly longer than the PSMA companion post because the implementation audience needs more context to find it credible. Each section earns its length.
The six sections are role clarity as the hidden trip wire, regulatory demystified, facility requirements without the vendor spin, radiopharmacy logistics as the scheduling backbone, the case for dosimetry investment, and reimbursement with honest nuance.
The voice is consistent with your established pattern — first person, direct, self-aware about being a physicist rather than a clinician, willing to say what vendors and regulators won't say plainly.
A few things worth noting before you publish:
The title is deliberately provocative — "what no one tells you up front" sets up a promise the post has to keep, and I think it does. If that framing feels too informal for your taste, an alternative is "Starting a 177Lu Program at a Community Hospital: What to Map Out Before Your First Patient."
The dosimetry section takes a clear position because you have one. If you want to soften the "programs that cut corners" framing slightly, that's easy to adjust — but I'd encourage leaving the substance intact.
The content architecture for this topic now looks like:
Blog post (this) → Full implementation guide PDF (still to build, now with a clear audience and scope informed by the blog) → Workshop as the live experience
That CTA box points to a guide that doesn't exist yet — worth building that next if this post is going live soon.
Arc blogpost gettingstarted 177lu
Document · DOCX
for this linkedin post, write an ARC website blog ahtat covers full workflow and role structure in community Lu-177 setting
For nuclear medicine technologists thinking about Lu-177 therapy programs at their institution:
The biggest operational question we hear isn't dosimetry. It isn't even regulatory.
It's: 'Who handles what, and how do we set up the workflow so nobody is doing something outside their scope?'
The short answer is that a functional Lu-177 program at a community hospital requires clarity across at least five roles before the first patient is treated:
— Nuclear medicine physician (therapy planning, dose prescription)
— Nuclear pharmacist or authorized user (radiopharmaceutical receipt and preparation)
— Nuclear medicine technologist (administration, imaging, patient monitoring)
— Medical physicist (dosimetry, radiation safety program)
— Referring provider (patient selection, follow-up coordination)
The challenge in community settings is that some of these roles may overlap, be unfilled, or require new credentialing. That's not a dealbreaker — but it has to be mapped out explicitly before you start.
Which of these roles is the hardest to fill or define at your institution? Genuinely curious.
Show more
3:28 PM
Synthesized LinkedIn content into comprehensive blog framework
Synthesized LinkedIn content into comprehensive blog framework
The blog post is ready. It's the most substantial piece in the ARC content library so far — appropriately, because the audience (NM technologists and program builders) will read deeply if the content earns it, and this does.
What's inside:
The first half covers the five core roles with a visual card for each — what the role owns, and a specific "in community settings, watch for" callout that flags the real-world gaps that trip programs up. The authorized user credential timing issue, the nuclear pharmacist ambiguity with commercial pharmacy partners, the physicist scope mismatch, the referring provider communication breakdown — all named plainly.
The second half walks the full 10-step patient workflow from referral receipt through post-therapy follow-up, with the role owner identified at each step and the specific failure modes called out. Steps 3 (pharmacy scheduling), 6 (administration protocol), and 10 (response assessment handoff) get the most detailed treatment because that's where community programs tend to have the most undocumented assumptions.
The closing question loops back explicitly to the LinkedIn post — "I asked this on LinkedIn and got honest answers, curious whether the blog audience matches" — which is a nice connective tissue move between channels.
The CTA points to a role mapping worksheet, which you don't have yet but should build — it's the natural lead magnet for this post, a more operationally useful download than a general guide. One page, table format, every workflow step with a blank "owner" column. That's a morning's work and a strong email capture offer for the NM professional audience.
The content stack for this topic now looks like:
LinkedIn Post 6 → This blog post → Role mapping worksheet (to build) → Workshop as live application
Arc blogpost workflowroles lu177
Document · DOCX
provide 5 title suggestions for this blog post and create a representative banner image that highlights the high level concept of the blog post
3:59 PM
Architected branded banner showcasing five interconnected clinical workflow roles
Architected branded banner showcasing five interconnected clinical workflow roles
Five title options:
Who Does What: Mapping Roles and Workflow for a Community Lu-177 Program (current — clear, direct, searchable)
The Five Roles Your Lu-177 Program Can't Launch Without (list-forward, high click potential)
Before the First Patient: A Community Hospital Lu-177 Workflow Guide (timeline framing, speaks to planners)
Nobody Hands You the Map: Building Role Clarity for Community Lu-177 Programs (callbacks to the blog voice, more editorial)
Scope, Sequence, and Ownership: The Operational Blueprint for Community Lu-177 Therapy (professional/administrative audience, more formal)
My recommendation is option 2 for the blog post title and option 1 as the SEO meta title — they serve different jobs.
Now for the banner:
The banner uses ARC's deep blue as the base, with each of the five roles color-coded distinctly — green for the referring provider, blue for the NM physician, purple for the nuclear pharmacist, teal for the NM technologist, and amber for the medical physicist. The numbered step badges and connecting arrows reinforce the workflow concept, and the faint atomic orbit rings in the background tie it visually to the nuclear medicine context without being heavy-handed.
Recommended title pairing with this banner:
Option 2 — "The Five Roles Your Lu-177 Program Can't Launch Without" — works best with this visual since the banner literally shows five numbered roles. The image and the headline tell the same story.
To export for Duda: right-click the banner → Save as SVG, or I can generate it as a PNG-ready file. Let me know which format Duda needs and I'll produce the file version.
make this as an html as duda won't let me format that in a nice way
Role 1 — Nuclear Medicine Physician / Authorized User
Owns:
• Patient evaluation and therapy eligibility determination
• Dose prescription — written directive for each treatment cycle
• Review of dosimetry data and therapy modification decisions
• Medical oversight of the radiation safety program for therapeutic use
• Consent process and patient and family education on radiation precautions
In community settings, watch for:
The authorized user designation is a specific NRC/Agreement State credential that not every nuclear medicine physician holds. Your physician may be authorized for diagnostic procedures but not therapeutic use of Lu-177 specifically. Verify this early — adding an authorized user to a radioactive materials license takes time, and your program cannot treat patients until it is done.
Show more
4:08 PM
Identified and corrected misaligned role titles across cards
Identified and corrected misaligned role titles across cards
The role titles got misaligned. Let me fix that with str_replace.
Edited 4 files, ran a command
Edited 4 files, ran a command
Here's a preview of how it renders:
Presented file
Presented file
The HTML file is ready to download. Here's how to drop it into Duda:
In your Duda editor, add an HTML widget (under the "Other" or "Advanced" widget category) to your blog post page. Open the widget, paste the full contents of this file, and save. It will render the accordion cards exactly as shown in the preview.
A few things worth knowing about the implementation:
Each card is collapsed by default with an expand/collapse toggle, so the page doesn't feel overwhelming on load. The "Expand all / Collapse all" button at the top handles bulk toggling. Each role has its color-coded left border and numbered badge matching the banner image, so the visual language is consistent if you use both on the same page. The fonts pull from Google Fonts (Source Serif 4 and DM Sans) — if Duda strips external font calls, it will gracefully fall back to Georgia and system sans-serif, which still looks clean.
If Duda's HTML widget has trouble with the Google Fonts tag in the , just remove those two lines and the fallback fonts will take over automatically.
Arc role cards
Code · HTML
integrate the role cards into this html after the paragraph "At an academic center these roles map cleanly to five or more different people with clearly defined scope. At a community hospital they may overlap, be split across part-time staff, or require building a new relationship with an outside partner. None of that is disqualifying — but every gap has to be explicitly addressed before you treat your first patient, not discovered during it."
Appalachian Radiotheranostics Coalition (ARC)
/
how could I create an automatic agent to post on linkedin as part of a scheduled campaign
Mar 12
Identified request for automated LinkedIn posting solution
Identified request for automated LinkedIn posting solution
Great use case for ARC content promotion! Here's how you could build this practically:
The Core Architecture
You'd need three pieces working together: a content source (your blog posts, episode releases, etc.), a scheduler, and a LinkedIn API connection. Python is well-suited for all of this.
LinkedIn API Access
This is the first real hurdle. LinkedIn's official API has become quite restrictive — you need to apply for Marketing Developer Platform access, which requires a company page and review process. The alternative many people use is their personal OAuth token, but those expire and automating refresh is fiddly. For a legitimate organizational campaign like ARC, going through the official Marketing API is the right path.
A Practical Stack
The simplest version that actually works reliably would be Python + a scheduling library (like schedule or APScheduler) running on a small cloud VM, or you could use GitHub Actions on a cron schedule if you want zero infrastructure. Content could live in a simple CSV or Google Sheet — date, post text, optional image, optional link.
A more powerful version would use the Claude API to generate post variations from your blog content automatically — you'd feed it the blog post and it drafts a LinkedIn-appropriate version in your voice, which you approve before it goes into the queue.
Biggest practical considerations for ARC specifically:
The dual-audience problem you already know well (technologists vs. referring physicians) matters a lot here — you'd want your content queue to tag which audience a post targets, and potentially manage two posting rhythms or personas.
Want me to build you a working Python script for this? I can start with a version that reads from a spreadsheet queue and posts on a schedule, with hooks to plug in the LinkedIn API credentials when you have them. Or if you want to explore the Claude-powered content generation piece first, we can start there.
What's your biggest constraint right now — getting LinkedIn API access, building the scheduler, or generating the content itself?
claude powered would be fine but can a claude agent post to my linkedin?
Mar 12
Evaluated Claude's API capabilities for autonomous LinkedIn posting
Evaluated Claude's API capabilities for autonomous LinkedIn posting
Short answer: not directly, no. Claude generates content within conversations but doesn't have persistent processes or the ability to take autonomous actions between sessions.
What you'd actually build is a Python script that acts as the agent — it calls the Claude API to write the posts, then calls the LinkedIn API to publish them. Claude is the brain, your script is the hands.
Here's what that loop looks like:
Your content queue (CSV/Sheet)
↓
Python scheduler triggers on date/time
↓
Calls Claude API → "Write a LinkedIn post for ARC based on this blog excerpt, targeting [technologists / referring physicians]"
↓
Claude returns draft post text
↓
(Optional) Human approval step
↓
Python calls LinkedIn API → publishes post
The honest friction points:
LinkedIn API access is the real gating factor. You need to apply for their Marketing Developer Platform, which requires a verified company page. Once approved you get proper OAuth tokens with refresh capability. Without that, any workaround is fragile.
A smarter starting point for ARC might be to build the content generation and approval pipeline first — Claude drafts posts from your blog content, they land in a review queue (even just a Google Sheet), you approve them, and then they post. That way you're never flying blind with automated publishing on an organizational account.
Want me to build the Python script for the Claude content generation piece? That part you can start testing today without waiting on LinkedIn API approval.
best way to setup an ARC group page on linkedin
Mar 12
Identified straightforward LinkedIn setup guidance for ARC
Identified straightforward LinkedIn setup guidance for ARC
Here's the practical breakdown:
Company Page vs. Group — pick the right one first
These are different things on LinkedIn. You probably want a Company Page for ARC, not a Group. A Company Page is a public-facing presence you can post from, build followers, and eventually connect to the API for automation. A Group is more of a discussion forum for members. For a coalition with a public education mission, Company Page is the right call.
Requirements to create a Company Page
You need a personal LinkedIn account in good standing, and LinkedIn will ask you to verify that you're affiliated with the organization. You'll need a real website (arctheranostics.org qualifies), and ideally a professional email on that domain.
Setup steps that actually matter for ARC:
The name should be "Appalachian Radiotheranostics Coalition" with ARC as the tagline — not the other way around, since most people won't know the acronym yet. Fill out every field LinkedIn gives you because it affects discoverability. "Medical and Health" is your industry category. The about section is prime real estate — lead with the mission and the Knoxville-to-Roanoke corridor framing rather than the grant language.
Things to get right from day one:
Get your custom URL locked in early (linkedin.com/company/arc-theranostics or similar) before someone else grabs anything close. Add both you and James as admins immediately. Upload a proper logo and banner — a bare page looks abandoned and undermines credibility when you're trying to get referring physicians to take you seriously.
The strategic consideration
Who "owns" the page matters for the long run. If it's tied to your personal UT account primarily, that creates complications as ARC grows. Worth thinking about whether the page admin structure reflects the coalition nature from the start.
Want help drafting the About section copy for the page?
should the coalition be incorporated
Mar 12
Weighed legal considerations while disclaiming professional expertise
Weighed legal considerations while disclaiming professional expertise
Good question to be asking now rather than later. I'm not a lawyer, so take this as a framework for the conversation you should have with one — but here's the practical landscape:
The case for incorporating sooner
The Mars Shot grant is currently flowing through UT, which works fine for this project. But if ARC is going to grow into a self-sustaining regional coalition — its own website, its own podcast, eventually its own funding — operating indefinitely under one institution's umbrella creates real constraints. You can't open a bank account, sign contracts, receive donations, or apply for many grants as an unincorporated initiative. You also create ambiguity about whether ARC's work product belongs to UT, to the individuals involved, or to the coalition.
The case for waiting
Incorporation has real overhead — filing fees, registered agent requirements, annual reports, board governance, tax filings. A 501(c)(3) specifically takes time and money to establish and maintain. If ARC is still primarily a grant-funded education program tied to institutional partners, the administrative burden may not be worth it yet.
Most likely right structure
A 501(c)(3) nonprofit is probably the eventual destination given ARC's mission — education, workforce development, community health access. That designation opens up foundation grants, tax-deductible donations, and credibility with health systems you're trying to bring into the coalition. It also cleanly separates ARC from UT and Carilion as institutions.
A practical middle path
Some coalitions start as a fiscally sponsored project under an existing nonprofit — essentially borrowing their tax-exempt status while you build the infrastructure to stand alone. SNMMI or a regional health foundation might be candidates for that conversation.
The questions worth answering first:
Do you and James envision ARC outliving the Mars Shot grant? Is there a realistic funding model beyond grants — membership dues, CME fees, industry partnerships? Who would sit on a board, and is there appetite for that governance structure?
Those answers will tell you whether you need a lawyer this year or next. Would it help to think through what an ARC funding model could look like?
yes. should be after and working on industry and membership funding
Mar 12
Strategized post-grant funding through industry and membership channels
Strategized post-grant funding through industry and membership channels
Good instinct to be thinking about this now. Here's how I'd frame the landscape:
The credibility window you have right now
The Mars Shot grant is legitimizing infrastructure. You're building the curriculum, the workshops, the online hub, the corridor relationships. That's exactly what industry partners and potential members need to see before they'll write checks. Use the grant period to document everything — attendance, outcomes, adoption metrics — because that becomes your pitch deck for the next phase.
Industry Funding
This is the most realistic near-term revenue and the Appalachian theranostics space makes the pitch fairly natural. The obvious targets are the companies who benefit directly from expanded community adoption:
Novartis (Lutathera, Pluvicto) and Lantheus (PYLARIFY) have the most direct commercial interest in exactly what ARC is doing — training the referring and treating providers who drive their therapy volumes. Both have medical affairs and health equity grant programs that fund exactly this kind of regional education infrastructure. The pitch isn't "sponsor us" it's "we're building the workforce that makes your therapies accessible in markets you can't reach alone."
Cardinal Health, PETNET, and other radiopharmacy networks also have skin in the game since community program growth means more dispensing volume.
The key guardrail is making sure industry funding doesn't compromise ARC's independence or CME accreditation potential. Structure it as unrestricted educational grants rather than sponsorships with strings, and keep that separation visible and documented.
Membership Funding
This is slower to build but more sustainable. The model that works for regional coalitions like ARC typically has two tiers:
Institutional members — hospitals and health systems along the corridor paying annual dues in the $2,500-$10,000 range depending on size. What they get is access to training materials, discounted workshop seats, the online hub, and eventually a voice in ARC's direction. For a community hospital trying to stand up a theranostics program, that's genuinely valuable.
Individual members — nuclear medicine physicians, technologists, physicists, and pharmacists paying something like $150-$300 annually for CME-eligible content access, networking, and the professional community ARC is building. This scales with your audience growth.
CME Accreditation is the unlock
If the workshops and online content carry CME/CEU credit, membership and content access become much easier to monetize. Providers have budget for CME that they don't have for generic association dues. Getting accredited through SNMMI or ACNM for your content is worth prioritizing in year two.
A realistic revenue picture for year two post-grant
Two or three industry educational grants at $25,000-$50,000 each is achievable if you go into those conversations with documented outcomes from the Mars Shot work. A founding institutional membership cohort of five to eight corridor hospitals at modest dues. Individual memberships building slowly. That's probably $150,000-$250,000 in year two if the outreach is active — enough to support a part-time executive director and keep the infrastructure running.
The incorporation timing this suggests
If industry funding conversations are starting during or right after the grant period, you need the 501(c)(3) in place before those checks need somewhere to go. That means filing probably six to nine months before the Mars Shot grant ends. A healthcare-focused nonprofit attorney can get you there for $3,000-$6,000 in legal fees plus filing costs.
The board question becomes important here too — industry partners and institutional members will want to see a governance structure that isn't just you and James. A five to seven person board with representation from nuclear medicine, referring physicians, a community hospital administrator, and ideally a patient advocate would signal that ARC is a real coalition and not a two-person operation.
Want to work through what an ARC pitch deck to industry partners might look like, or sketch out the board structure first?
what do you suggest for a linkedin campaign to engage and grow engagment with arc
Mar 12
Given where ARC is right now — grant funded, building credibility, dual audience — here's how I'd think about it strategically before getting tactical:
The core LinkedIn reality for ARC
LinkedIn's algorithm heavily rewards consistency and conversation over broadcasting. A lot of healthcare organizations make the mistake of using it as a press release channel. For ARC specifically, the goal isn't just followers — it's getting the right 200 people in the Appalachian corridor deeply engaged, because those are the referring physicians, technologists, and health system administrators who become members, workshop attendees, and eventually evangelists.
The content pillars I'd build around
Each pillar serves a purpose and maps to your dual audience:
Education as a hook — short, practical theranostics content. "What a referring urologist needs to know before their first PSMA referral" type posts. These position ARC as genuinely useful, not just self-promotional, and they travel well through shares.
The Appalachian angle — cancer mortality data, patient access stories, the corridor framing. This is emotionally resonant and differentiates ARC from any generic theranostics education content. Nobody else owns this story.
Behind the scenes of building ARC — the workshop prep, the grant work, James on the ground in Roanoke, you at UT. People follow people more than organizations, especially in professional communities. This humanizes the coalition.
Outcome and impact updates — workshop attendance, new sites coming online, provider confidence metrics from your pre/post assessments. This builds the evidence base publicly and feeds the industry funding narrative simultaneously.
Podcast episode amplification — each new episode is a content opportunity not just for a link post but for pulling out a key insight or quote and making it a standalone post that drives back to the episode.
The posting rhythm that actually works
Three to four posts per week on the Company Page is the sweet spot — enough to stay in the feed without burning out your content supply. More important than frequency is that you and James are personally engaging from your individual profiles. Comments and reshares from personal accounts dramatically outperform company page posts in reach. The company page builds the brand; your personal profiles build the community.
The campaign arc I'd suggest for launch
The first thirty days should be a founding story campaign — why ARC exists, what the Appalachian corridor looks like in terms of cancer burden, what theranostics could do for patients who currently can't access it, and who you and James are. Tell the origin story in pieces across multiple posts rather than one long about section nobody reads.
Days thirty to ninety shift into education and engagement — the practical content pillars, starting to use polls ("What's the biggest barrier to theranostics adoption at your institution?"), asking questions that get comments from your target audience.
After ninety days you should have enough data from LinkedIn analytics to know what's resonating and double down.
The tactics that move the needle fastest for a new page
Getting your existing network to follow and engage in the first two weeks matters a lot because LinkedIn uses early engagement signals to decide how widely to distribute your content. A direct personal ask to colleagues, workshop attendees, and SNMMI connections to follow the page will accelerate this faster than any algorithmic strategy.
Tagging partner institutions — UT Medical Center, Carilion Clinic, ETSU — in relevant posts gets you in front of their follower bases. Tagging SNMMI when you post content relevant to their mission does the same.
LinkedIn newsletters are underused and get significantly better reach than regular posts right now. A monthly ARC newsletter distributed through LinkedIn covering theranostics adoption news in the region would build a subscriber base independently of your follower count.
The honest constraint
All of this requires consistent execution over six to twelve months before the compounding effect kicks in. The biggest risk for a small operation like ARC is starting strong and then going quiet when grant work gets busy. That's where the automated content pipeline we discussed earlier actually earns its value — having three weeks of posts queued and scheduled means the page stays active even when you're heads down on workshops.
Want me to draft the first month of posts as a content calendar you could start working from?
how to engage on linkedin but drive to website for blog posts, content, etc.
Mar 12
Synthesized LinkedIn engagement strategy to redirect audience toward content
Synthesized LinkedIn engagement strategy to redirect audience toward content
This is the right strategic instinct — LinkedIn builds the audience, your website owns the relationship. Here's how to do it effectively:
The fundamental LinkedIn constraint you need to know
LinkedIn's algorithm actively suppresses posts that contain external links because they want people to stay on LinkedIn. A post with a link in it will get roughly 50-70% less organic reach than a post without one. This is the core tension you're working around.
The workaround that actually works
The "link in comments" method is the most reliable approach. You post compelling content natively on LinkedIn — no link — and then in the first comment you post the link to the full article. Your post gets full algorithmic reach, and people who want more click through. It looks like this:
Post body: The full hook, enough value to stand alone, ending with "Full breakdown in the comments 👇"
First comment: "For the full post including the referral pathway framework we use at UT: [link]"
This consistently outperforms putting the link directly in the post.
The content bridge model
Think of each LinkedIn post as a trailer for the website content, not a summary of it. The post delivers genuine standalone value but leaves something unresolved that only the full article answers. For ARC specifically this might look like:
LinkedIn post: "We've seen three consistent barriers when community hospitals try to stand up their first Lu-177 program. The first one surprises most people — it's not regulatory, and it's not reimbursement."
Website: The full post covering all three barriers with actionable frameworks.
The LinkedIn post works on its own but creates enough curiosity that the motivated reader — exactly who you want — clicks through.
Content formats that drive clicks most effectively
Teasers with a clear "more at the link" hook work well but only if the LinkedIn content genuinely delivers partial value first. Nobody clicks "read our new blog post" but they do click when they've already gotten something useful and want the rest.
Carousels — LinkedIn's multi-image slide format — get strong organic reach and you can use the last slide as a CTA pointing to the website. A five-slide carousel on "What referring oncologists need to know about Lu-177 PSMA" with the final slide being "Download the full provider guide at arctheranostics.org" works well for your audience.
Polls are highly distributed by the algorithm and you can close the loop by posting the results with a link to a related article. "We asked 200 nuclear medicine professionals what their biggest theranostics barrier was. Here's what they said — and what the data tells us about solving it: [link]"
The email list is actually the real goal
LinkedIn followers are LinkedIn's asset, not yours. Website visitors you can convert to email subscribers are yours permanently regardless of what LinkedIn's algorithm does next year. Every piece of LinkedIn content should ultimately be working toward getting the right people onto your email list through the website. A simple lead magnet — a downloadable referral pathway template, a Lu-177 program readiness checklist, a community theranostics implementation guide — gives people a reason to hand over their email when they land on the site.
UTM parameters — don't skip this
Every link you post from LinkedIn to your website should have a UTM tag appended so you can see in Google Analytics exactly how much traffic LinkedIn is driving and which posts are most effective. A simple format like:
arctheranostics.org/blog/post-title?utm_source=linkedin&utm_medium=social&utm_campaign=blog
This takes thirty seconds to set up and tells you within ninety days which content pillars are actually driving your target audience to the site versus just getting LinkedIn engagement.
The content recycling loop
One piece of website content should generate multiple LinkedIn touchpoints rather than one post and done. A single blog post on referral barriers becomes a carousel, then a poll on the topic, then a comment engagement post sharing a reader response, then a podcast episode, then a LinkedIn newsletter entry — all pointing back to the original article. This is how small teams create the appearance of a robust content operation without burning out.
The practical setup on your Duda site
Make sure every blog post has a clear email capture — even just a "subscribe for updates" sidebar — and that social sharing buttons are visible. Add Open Graph meta tags to your posts so that when someone does share a link directly on LinkedIn it pulls a clean image and description rather than a blank preview. That alone meaningfully improves click-through on shared content.
Want me to map out a specific content recycling plan for one of your existing blog posts as a concrete example of how this loop works in practice?
how to add subscribe for updates on duda
Mar 12
Surveyed Duda's built-in email capture and subscription features
Surveyed Duda's built-in email capture and subscription features
Duda has a few native options and some third-party approaches — here's the practical breakdown:
Duda's Built-in Form Widget
The simplest path is Duda's native form widget. Drag it onto the page, strip it down to a single email field and a submit button, and connect it to Duda's built-in contact list. The limitation is that Duda's native form just stores submissions in your dashboard — it doesn't give you email marketing capability on its own. Fine for collecting emails, not fine for actually sending a newsletter.
The better approach — connect to an email platform
You want the form submissions flowing directly into an email marketing tool. The two most practical options for where ARC is right now:
Mailchimp has a native Duda integration. In Duda's App Market you can find the Mailchimp integration, connect your account, and any form submission automatically adds the subscriber to a list. Mailchimp's free tier handles up to 500 contacts which gets you started without cost.
Kit (formerly ConvertKit) is worth considering if the LinkedIn newsletter and content automation direction appeals to you — it's built more around creator and content workflows than Mailchimp's broadcast model.
Where to place the subscribe element
Several places work better than others for ARC specifically:
A persistent sidebar widget on every blog post page is the highest value placement — someone reading your content is already the right person to capture.
A footer subscription bar sitewide so it appears regardless of what page someone lands on.
A mid-post inline form after your first or second content section — not a popup, just an embedded "get posts like this in your inbox" form within the article flow. These convert well without being intrusive.
A dedicated landing page at something like arctheranostics.org/subscribe that you can point to directly from LinkedIn posts and your podcast show notes.
The lead magnet approach on Duda
Rather than just "subscribe for updates" — which has low conversion — pair the form with a content offer. On Duda you'd create a simple section with the offer described, the email form, and set up an automated confirmation email that delivers the download link. A "Community Theranostics Readiness Checklist" or "Lu-177 Referral Pathway Template" as a downloadable PDF would convert significantly better than a generic subscribe ask, and it immediately self-selects for your most engaged audience.
The actual Duda steps
Go to your page editor and add a new section where you want the form. Add the Form widget from the widget panel. In form settings, add a single field for email address, set the submit button text to something specific like "Send me the guide" rather than "Submit." Under form settings find the integrations tab and connect either Mailchimp or your chosen platform. Set up a thank you message or redirect to a thank you page.
For the sidebar specifically, Duda handles this through their column layout — you'd set your blog post template to a two-column layout with the subscribe form widget in the narrower right column.
One Duda-specific thing to check
Depending on your plan tier, some integrations and the ability to edit the blog post template layout may be restricted. If you hit a wall on the blog template specifically, the workaround is adding the form section manually to each post — tedious but functional until you're on a plan that supports template-level editing.
Want me to draft the copy for the subscribe section and the lead magnet offer so you have that ready when you set it up?
create 4 weeks of posts as you suggest for linked in
Mar 12
Orchestrated four weeks of LinkedIn content strategy
Orchestrated four weeks of LinkedIn content strategy
The full 4-week calendar is ready to download. Here's what's inside:
16 posts total — 4 per week structured across the pillars we discussed:
Week 1 — Founding story: What theranostics is, the Appalachian corridor data, meet Dustin and James, the Mars Shot grant announcement
Week 2 — Education hook: Referring physician barriers to Lu-177 PSMA, technologist workflow setup, a poll on implementation barriers, a case-based scenario for oncologists
Week 3 — Appalachia + behind the scenes: Community-first design philosophy, curriculum development in progress, cancer mortality data with narrative, podcast launch
Week 4 — Impact and CTA: Poll results follow-up, podcast episode amplification, workshop registration preview, campaign close and thank you
Every post includes the post body (no link, for algorithm reach), the first comment with the link placeholder, and notes on tagging, images, and resharing strategy.
There's also an appendix with a pre-posting checklist, UTM tag template, optimal posting times by day, and a 30-day analytics review guide.
A few things to do before you post: swap in live arctheranostics.org URLs with UTM tags, fill in the poll results on Post 13 once that closes, and line up James for personal reshares — his amplification on the technologist-facing posts especially will meaningfully extend the reach.
Arc linkedin calendar
Document · DOCX
create a referring provider overview for 177Lu-PSAM as described in week 2 post 5
Mar 16
Architected comprehensive provider guide covering patient criteria, referral pathways, and support resources
Architected comprehensive provider guide covering patient criteria, referral pathways, and support resources
Good content marketing — this resource is referenced in Post 5 and drives the click-through. I'll write it in your established blog voice and format it as a document you can post directly to the site or use as a downloadable lead magnet.
Assembled medical overview document for provider reference
Assembled medical overview document for provider reference
The guide is ready. Here's what's inside:
Structure follows your established blog voice — first-person, direct, self-aware, written for both a busy urologist and a motivated technologist without condescending to either.
Nine sections covering:
What theranostics actually is and how the PSMA mechanism works
Full VISION trial eligibility criteria in a color-coded table (green = include, red = watch carefully)
Direct answers to the three barriers from Post 5 — with the honest version of each answer, not the marketing version
A 6-step referral pathway in visual step boxes
What to tell your patient before the referral
A brief DOTATATE/NET parallel for endocrinologists who find the post
A documentation checklist table for smooth referrals
Common clinical questions (concurrent ADT, systemic therapy, earlier disease use, re-treatment)
A closing that loops back to the ARC workshop CTA
Two deployment options: post it as a long-form blog entry on arctheranostics.org, or convert it to PDF and use it as the lead magnet for your Duda subscribe form — "Download our referring provider guide to 177Lu-PSMA" is a strong conversion offer for the right audience.
A few places to personalize before publishing: the referral contact info section (once the ARC directory is live), and the closing question which I left open-ended for you to adjust based on what you want to drive in comments.
Arc 177lupsma referringproviderguide
Document · DOCX
should this be a blog post?
Mar 16
Weighed publishing formats and advocated hybrid blog-plus-download strategy
Weighed publishing formats and advocated hybrid blog-plus-download strategy
Honest answer: it's too long and too dense to work well as a standalone blog post, but it's almost perfect as a lead magnet PDF — which is actually more valuable strategically.
Here's why the distinction matters:
The blog post problem
That document is about 2,500 words with tables, clinical criteria, and a 6-step pathway. A reader landing on your blog from LinkedIn on their phone between clinic patients isn't going to read it linearly. They'll skim, lose the thread, and leave. Long-form clinical content that reads like a resource guide doesn't perform as blog content — it performs as something you download and refer back to.
What you actually want is both
A shorter blog post — 600 to 800 words — that covers the same territory at a higher level, written in your voice, ending with a CTA to download the full guide. The blog post is the trailer. The PDF is the film. The email capture happens at the handoff between the two.
That structure also gives Post 5 in the LinkedIn calendar its natural link destination: the blog post, not the PDF directly. Someone clicks through from LinkedIn, reads the post, decides they want the full referral guide, enters their email, gets the PDF. You've now converted a LinkedIn follower into an email subscriber who self-identified as a referring provider.
The PDF as a lead magnet also travels differently
A referring physician who downloads it can forward it to a colleague, print it for a department meeting, or keep it in a folder for when the right patient shows up. Blog posts don't behave that way.
Want me to write the companion blog post version — shorter, conversational, in your voice — that drives to the PDF download?
write companion blog post
Mar 16
Synthesized concise blog post companion piece
Synthesized concise blog post companion piece
The blog post is ready. A few things worth noting about how it's structured:
The title is designed to stop the scroll — "Your Patient Is Probably a Theranostics Candidate. Here's How to Know." speaks directly to the referring physician's self-interest without being clickbait. It implies the reader may already be missing something, which creates enough tension to read on.
It runs about 900 words — slightly above the 600-800 target but every section earns its place. You can trim the opening paragraph if it feels too long once you read it in your own voice.
The CTA box is embedded mid-page after the referral pathway section — not just at the bottom. Someone who's read far enough to understand the referral process is your highest-intent reader. That's where to capture them.
One thing to do before publishing: the closing question placeholder. I left it flagged with a suggested prompt — something like asking readers to drop their lingering theranostics question in the comments. That's the kind of thing that works better in your voice than mine, so I left it for you to write in.
The content flow between the three pieces now looks like this:
LinkedIn Post 5 → Blog post (trailer, ~900 words) → PDF guide download (full resource, gated by email)
Each layer serves the reader who wants to go deeper while capturing the ones who stop at each level. That's the architecture working the way it should.
Arc blogpost 177lupsma referringprovider
Document · DOCX
create a guide on getting started with 177LU therapies
Mar 16
Deliberated on awaiting user input before proceeding
Deliberated on awaiting user input before proceeding
Before I build this, one framing question — because it changes the document significantly:
Take a second to answer those two questions and I'll build the right document. The audience question especially matters — the technologist version reads like an operations manual, the physician/admin version reads more like a program launch decision framework with business case language. Getting that wrong means the guide lands with the wrong person or speaks past the right one.
make this in to a blog post
Mar 16
Resolved ambiguity and charted blog post strategy independently
Resolved ambiguity and charted blog post strategy independently
Got it — I'll write it directly as a blog post in your voice, targeting the broadest useful audience (community hospital NM professionals and program leaders), and covering the key getting-started themes at blog depth rather than guide depth. Same structure as the PSMA companion post — conversational, bolded section headers, closing question placeholder, CTA for a future full guide.
Ran 2 commands, created a file, read a file
Ran 2 commands, created a file, read a file
The blog post is ready. Here's how it's structured:
Six sections, roughly 1,200 words — slightly longer than the PSMA companion post because the implementation audience needs more context to find it credible. Each section earns its length.
The six sections are role clarity as the hidden trip wire, regulatory demystified, facility requirements without the vendor spin, radiopharmacy logistics as the scheduling backbone, the case for dosimetry investment, and reimbursement with honest nuance.
The voice is consistent with your established pattern — first person, direct, self-aware about being a physicist rather than a clinician, willing to say what vendors and regulators won't say plainly.
A few things worth noting before you publish:
The title is deliberately provocative — "what no one tells you up front" sets up a promise the post has to keep, and I think it does. If that framing feels too informal for your taste, an alternative is "Starting a 177Lu Program at a Community Hospital: What to Map Out Before Your First Patient."
The dosimetry section takes a clear position because you have one. If you want to soften the "programs that cut corners" framing slightly, that's easy to adjust — but I'd encourage leaving the substance intact.
The content architecture for this topic now looks like:
Blog post (this) → Full implementation guide PDF (still to build, now with a clear audience and scope informed by the blog) → Workshop as the live experience
That CTA box points to a guide that doesn't exist yet — worth building that next if this post is going live soon.
Arc blogpost gettingstarted 177lu
Document · DOCX
for this linkedin post, write an ARC website blog ahtat covers full workflow and role structure in community Lu-177 setting
For nuclear medicine technologists thinking about Lu-177 therapy programs at their institution:
The biggest operational question we hear isn't dosimetry. It isn't even regulatory.
It's: 'Who handles what, and how do we set up the workflow so nobody is doing something outside their scope?'
The short answer is that a functional Lu-177 program at a community hospital requires clarity across at least five roles before the first patient is treated:
— Nuclear medicine physician (therapy planning, dose prescription)
— Nuclear pharmacist or authorized user (radiopharmaceutical receipt and preparation)
— Nuclear medicine technologist (administration, imaging, patient monitoring)
— Medical physicist (dosimetry, radiation safety program)
— Referring provider (patient selection, follow-up coordination)
The challenge in community settings is that some of these roles may overlap, be unfilled, or require new credentialing. That's not a dealbreaker — but it has to be mapped out explicitly before you start.
Which of these roles is the hardest to fill or define at your institution? Genuinely curious.
Show more
3:28 PM
Synthesized LinkedIn content into comprehensive blog framework
Synthesized LinkedIn content into comprehensive blog framework
The blog post is ready. It's the most substantial piece in the ARC content library so far — appropriately, because the audience (NM technologists and program builders) will read deeply if the content earns it, and this does.
What's inside:
The first half covers the five core roles with a visual card for each — what the role owns, and a specific "in community settings, watch for" callout that flags the real-world gaps that trip programs up. The authorized user credential timing issue, the nuclear pharmacist ambiguity with commercial pharmacy partners, the physicist scope mismatch, the referring provider communication breakdown — all named plainly.
The second half walks the full 10-step patient workflow from referral receipt through post-therapy follow-up, with the role owner identified at each step and the specific failure modes called out. Steps 3 (pharmacy scheduling), 6 (administration protocol), and 10 (response assessment handoff) get the most detailed treatment because that's where community programs tend to have the most undocumented assumptions.
The closing question loops back explicitly to the LinkedIn post — "I asked this on LinkedIn and got honest answers, curious whether the blog audience matches" — which is a nice connective tissue move between channels.
The CTA points to a role mapping worksheet, which you don't have yet but should build — it's the natural lead magnet for this post, a more operationally useful download than a general guide. One page, table format, every workflow step with a blank "owner" column. That's a morning's work and a strong email capture offer for the NM professional audience.
The content stack for this topic now looks like:
LinkedIn Post 6 → This blog post → Role mapping worksheet (to build) → Workshop as live application
Arc blogpost workflowroles lu177
Document · DOCX
provide 5 title suggestions for this blog post and create a representative banner image that highlights the high level concept of the blog post
3:59 PM
Architected branded banner showcasing five interconnected clinical workflow roles
Architected branded banner showcasing five interconnected clinical workflow roles
Five title options:
Who Does What: Mapping Roles and Workflow for a Community Lu-177 Program (current — clear, direct, searchable)
The Five Roles Your Lu-177 Program Can't Launch Without (list-forward, high click potential)
Before the First Patient: A Community Hospital Lu-177 Workflow Guide (timeline framing, speaks to planners)
Nobody Hands You the Map: Building Role Clarity for Community Lu-177 Programs (callbacks to the blog voice, more editorial)
Scope, Sequence, and Ownership: The Operational Blueprint for Community Lu-177 Therapy (professional/administrative audience, more formal)
My recommendation is option 2 for the blog post title and option 1 as the SEO meta title — they serve different jobs.
Now for the banner:
The banner uses ARC's deep blue as the base, with each of the five roles color-coded distinctly — green for the referring provider, blue for the NM physician, purple for the nuclear pharmacist, teal for the NM technologist, and amber for the medical physicist. The numbered step badges and connecting arrows reinforce the workflow concept, and the faint atomic orbit rings in the background tie it visually to the nuclear medicine context without being heavy-handed.
Recommended title pairing with this banner:
Option 2 — "The Five Roles Your Lu-177 Program Can't Launch Without" — works best with this visual since the banner literally shows five numbered roles. The image and the headline tell the same story.
To export for Duda: right-click the banner → Save as SVG, or I can generate it as a PNG-ready file. Let me know which format Duda needs and I'll produce the file version.
make this as an html as duda won't let me format that in a nice way
Role 1 — Nuclear Medicine Physician / Authorized User
Owns:
• Patient evaluation and therapy eligibility determination
• Dose prescription — written directive for each treatment cycle
• Review of dosimetry data and therapy modification decisions
• Medical oversight of the radiation safety program for therapeutic use
• Consent process and patient and family education on radiation precautions
In community settings, watch for:
The authorized user designation is a specific NRC/Agreement State credential that not every nuclear medicine physician holds. Your physician may be authorized for diagnostic procedures but not therapeutic use of Lu-177 specifically. Verify this early — adding an authorized user to a radioactive materials license takes time, and your program cannot treat patients until it is done.
Show more
4:08 PM
Identified and corrected misaligned role titles across cards
Identified and corrected misaligned role titles across cards
The role titles got misaligned. Let me fix that with str_replace.
Edited 4 files, ran a command
Edited 4 files, ran a command
Here's a preview of how it renders:
Presented file
Presented file
The HTML file is ready to download. Here's how to drop it into Duda:
In your Duda editor, add an HTML widget (under the "Other" or "Advanced" widget category) to your blog post page. Open the widget, paste the full contents of this file, and save. It will render the accordion cards exactly as shown in the preview.
A few things worth knowing about the implementation:
Each card is collapsed by default with an expand/collapse toggle, so the page doesn't feel overwhelming on load. The "Expand all / Collapse all" button at the top handles bulk toggling. Each role has its color-coded left border and numbered badge matching the banner image, so the visual language is consistent if you use both on the same page. The fonts pull from Google Fonts (Source Serif 4 and DM Sans) — if Duda strips external font calls, it will gracefully fall back to Georgia and system sans-serif, which still looks clean.
If Duda's HTML widget has trouble with the Google Fonts tag in the , just remove those two lines and the fallback fonts will take over automatically.
Arc role cards
Code · HTML
integrate the role cards into this html after the paragraph "At an academic center these roles map cleanly to five or more different people with clearly defined scope. At a community hospital they may overlap, be split across part-time staff, or require building a new relationship with an outside partner. None of that is disqualifying — but every gap has to be explicitly addressed before you treat your first patient, not discovered during it."
Appalachian Radiotheranostics Coalition (ARC)
/
how could I create an automatic agent to post on linkedin as part of a scheduled campaign
Mar 12
Identified request for automated LinkedIn posting solution
Identified request for automated LinkedIn posting solution
Great use case for ARC content promotion! Here's how you could build this practically:
The Core Architecture
You'd need three pieces working together: a content source (your blog posts, episode releases, etc.), a scheduler, and a LinkedIn API connection. Python is well-suited for all of this.
LinkedIn API Access
This is the first real hurdle. LinkedIn's official API has become quite restrictive — you need to apply for Marketing Developer Platform access, which requires a company page and review process. The alternative many people use is their personal OAuth token, but those expire and automating refresh is fiddly. For a legitimate organizational campaign like ARC, going through the official Marketing API is the right path.
A Practical Stack
The simplest version that actually works reliably would be Python + a scheduling library (like schedule or APScheduler) running on a small cloud VM, or you could use GitHub Actions on a cron schedule if you want zero infrastructure. Content could live in a simple CSV or Google Sheet — date, post text, optional image, optional link.
A more powerful version would use the Claude API to generate post variations from your blog content automatically — you'd feed it the blog post and it drafts a LinkedIn-appropriate version in your voice, which you approve before it goes into the queue.
Biggest practical considerations for ARC specifically:
The dual-audience problem you already know well (technologists vs. referring physicians) matters a lot here — you'd want your content queue to tag which audience a post targets, and potentially manage two posting rhythms or personas.
Want me to build you a working Python script for this? I can start with a version that reads from a spreadsheet queue and posts on a schedule, with hooks to plug in the LinkedIn API credentials when you have them. Or if you want to explore the Claude-powered content generation piece first, we can start there.
What's your biggest constraint right now — getting LinkedIn API access, building the scheduler, or generating the content itself?
claude powered would be fine but can a claude agent post to my linkedin?
Mar 12
Evaluated Claude's API capabilities for autonomous LinkedIn posting
Evaluated Claude's API capabilities for autonomous LinkedIn posting
Short answer: not directly, no. Claude generates content within conversations but doesn't have persistent processes or the ability to take autonomous actions between sessions.
What you'd actually build is a Python script that acts as the agent — it calls the Claude API to write the posts, then calls the LinkedIn API to publish them. Claude is the brain, your script is the hands.
Here's what that loop looks like:
Your content queue (CSV/Sheet)
↓
Python scheduler triggers on date/time
↓
Calls Claude API → "Write a LinkedIn post for ARC based on this blog excerpt, targeting [technologists / referring physicians]"
↓
Claude returns draft post text
↓
(Optional) Human approval step
↓
Python calls LinkedIn API → publishes post
The honest friction points:
LinkedIn API access is the real gating factor. You need to apply for their Marketing Developer Platform, which requires a verified company page. Once approved you get proper OAuth tokens with refresh capability. Without that, any workaround is fragile.
A smarter starting point for ARC might be to build the content generation and approval pipeline first — Claude drafts posts from your blog content, they land in a review queue (even just a Google Sheet), you approve them, and then they post. That way you're never flying blind with automated publishing on an organizational account.
Want me to build the Python script for the Claude content generation piece? That part you can start testing today without waiting on LinkedIn API approval.
best way to setup an ARC group page on linkedin
Mar 12
Identified straightforward LinkedIn setup guidance for ARC
Identified straightforward LinkedIn setup guidance for ARC
Here's the practical breakdown:
Company Page vs. Group — pick the right one first
These are different things on LinkedIn. You probably want a Company Page for ARC, not a Group. A Company Page is a public-facing presence you can post from, build followers, and eventually connect to the API for automation. A Group is more of a discussion forum for members. For a coalition with a public education mission, Company Page is the right call.
Requirements to create a Company Page
You need a personal LinkedIn account in good standing, and LinkedIn will ask you to verify that you're affiliated with the organization. You'll need a real website (arctheranostics.org qualifies), and ideally a professional email on that domain.
Setup steps that actually matter for ARC:
The name should be "Appalachian Radiotheranostics Coalition" with ARC as the tagline — not the other way around, since most people won't know the acronym yet. Fill out every field LinkedIn gives you because it affects discoverability. "Medical and Health" is your industry category. The about section is prime real estate — lead with the mission and the Knoxville-to-Roanoke corridor framing rather than the grant language.
Things to get right from day one:
Get your custom URL locked in early (linkedin.com/company/arc-theranostics or similar) before someone else grabs anything close. Add both you and James as admins immediately. Upload a proper logo and banner — a bare page looks abandoned and undermines credibility when you're trying to get referring physicians to take you seriously.
The strategic consideration
Who "owns" the page matters for the long run. If it's tied to your personal UT account primarily, that creates complications as ARC grows. Worth thinking about whether the page admin structure reflects the coalition nature from the start.
Want help drafting the About section copy for the page?
should the coalition be incorporated
Mar 12
Weighed legal considerations while disclaiming professional expertise
Weighed legal considerations while disclaiming professional expertise
Good question to be asking now rather than later. I'm not a lawyer, so take this as a framework for the conversation you should have with one — but here's the practical landscape:
The case for incorporating sooner
The Mars Shot grant is currently flowing through UT, which works fine for this project. But if ARC is going to grow into a self-sustaining regional coalition — its own website, its own podcast, eventually its own funding — operating indefinitely under one institution's umbrella creates real constraints. You can't open a bank account, sign contracts, receive donations, or apply for many grants as an unincorporated initiative. You also create ambiguity about whether ARC's work product belongs to UT, to the individuals involved, or to the coalition.
The case for waiting
Incorporation has real overhead — filing fees, registered agent requirements, annual reports, board governance, tax filings. A 501(c)(3) specifically takes time and money to establish and maintain. If ARC is still primarily a grant-funded education program tied to institutional partners, the administrative burden may not be worth it yet.
Most likely right structure
A 501(c)(3) nonprofit is probably the eventual destination given ARC's mission — education, workforce development, community health access. That designation opens up foundation grants, tax-deductible donations, and credibility with health systems you're trying to bring into the coalition. It also cleanly separates ARC from UT and Carilion as institutions.
A practical middle path
Some coalitions start as a fiscally sponsored project under an existing nonprofit — essentially borrowing their tax-exempt status while you build the infrastructure to stand alone. SNMMI or a regional health foundation might be candidates for that conversation.
The questions worth answering first:
Do you and James envision ARC outliving the Mars Shot grant? Is there a realistic funding model beyond grants — membership dues, CME fees, industry partnerships? Who would sit on a board, and is there appetite for that governance structure?
Those answers will tell you whether you need a lawyer this year or next. Would it help to think through what an ARC funding model could look like?
yes. should be after and working on industry and membership funding
Mar 12
Strategized post-grant funding through industry and membership channels
Strategized post-grant funding through industry and membership channels
Good instinct to be thinking about this now. Here's how I'd frame the landscape:
The credibility window you have right now
The Mars Shot grant is legitimizing infrastructure. You're building the curriculum, the workshops, the online hub, the corridor relationships. That's exactly what industry partners and potential members need to see before they'll write checks. Use the grant period to document everything — attendance, outcomes, adoption metrics — because that becomes your pitch deck for the next phase.
Industry Funding
This is the most realistic near-term revenue and the Appalachian theranostics space makes the pitch fairly natural. The obvious targets are the companies who benefit directly from expanded community adoption:
Novartis (Lutathera, Pluvicto) and Lantheus (PYLARIFY) have the most direct commercial interest in exactly what ARC is doing — training the referring and treating providers who drive their therapy volumes. Both have medical affairs and health equity grant programs that fund exactly this kind of regional education infrastructure. The pitch isn't "sponsor us" it's "we're building the workforce that makes your therapies accessible in markets you can't reach alone."
Cardinal Health, PETNET, and other radiopharmacy networks also have skin in the game since community program growth means more dispensing volume.
The key guardrail is making sure industry funding doesn't compromise ARC's independence or CME accreditation potential. Structure it as unrestricted educational grants rather than sponsorships with strings, and keep that separation visible and documented.
Membership Funding
This is slower to build but more sustainable. The model that works for regional coalitions like ARC typically has two tiers:
Institutional members — hospitals and health systems along the corridor paying annual dues in the $2,500-$10,000 range depending on size. What they get is access to training materials, discounted workshop seats, the online hub, and eventually a voice in ARC's direction. For a community hospital trying to stand up a theranostics program, that's genuinely valuable.
Individual members — nuclear medicine physicians, technologists, physicists, and pharmacists paying something like $150-$300 annually for CME-eligible content access, networking, and the professional community ARC is building. This scales with your audience growth.
CME Accreditation is the unlock
If the workshops and online content carry CME/CEU credit, membership and content access become much easier to monetize. Providers have budget for CME that they don't have for generic association dues. Getting accredited through SNMMI or ACNM for your content is worth prioritizing in year two.
A realistic revenue picture for year two post-grant
Two or three industry educational grants at $25,000-$50,000 each is achievable if you go into those conversations with documented outcomes from the Mars Shot work. A founding institutional membership cohort of five to eight corridor hospitals at modest dues. Individual memberships building slowly. That's probably $150,000-$250,000 in year two if the outreach is active — enough to support a part-time executive director and keep the infrastructure running.
The incorporation timing this suggests
If industry funding conversations are starting during or right after the grant period, you need the 501(c)(3) in place before those checks need somewhere to go. That means filing probably six to nine months before the Mars Shot grant ends. A healthcare-focused nonprofit attorney can get you there for $3,000-$6,000 in legal fees plus filing costs.
The board question becomes important here too — industry partners and institutional members will want to see a governance structure that isn't just you and James. A five to seven person board with representation from nuclear medicine, referring physicians, a community hospital administrator, and ideally a patient advocate would signal that ARC is a real coalition and not a two-person operation.
Want to work through what an ARC pitch deck to industry partners might look like, or sketch out the board structure first?
what do you suggest for a linkedin campaign to engage and grow engagment with arc
Mar 12
Given where ARC is right now — grant funded, building credibility, dual audience — here's how I'd think about it strategically before getting tactical:
The core LinkedIn reality for ARC
LinkedIn's algorithm heavily rewards consistency and conversation over broadcasting. A lot of healthcare organizations make the mistake of using it as a press release channel. For ARC specifically, the goal isn't just followers — it's getting the right 200 people in the Appalachian corridor deeply engaged, because those are the referring physicians, technologists, and health system administrators who become members, workshop attendees, and eventually evangelists.
The content pillars I'd build around
Each pillar serves a purpose and maps to your dual audience:
Education as a hook — short, practical theranostics content. "What a referring urologist needs to know before their first PSMA referral" type posts. These position ARC as genuinely useful, not just self-promotional, and they travel well through shares.
The Appalachian angle — cancer mortality data, patient access stories, the corridor framing. This is emotionally resonant and differentiates ARC from any generic theranostics education content. Nobody else owns this story.
Behind the scenes of building ARC — the workshop prep, the grant work, James on the ground in Roanoke, you at UT. People follow people more than organizations, especially in professional communities. This humanizes the coalition.
Outcome and impact updates — workshop attendance, new sites coming online, provider confidence metrics from your pre/post assessments. This builds the evidence base publicly and feeds the industry funding narrative simultaneously.
Podcast episode amplification — each new episode is a content opportunity not just for a link post but for pulling out a key insight or quote and making it a standalone post that drives back to the episode.
The posting rhythm that actually works
Three to four posts per week on the Company Page is the sweet spot — enough to stay in the feed without burning out your content supply. More important than frequency is that you and James are personally engaging from your individual profiles. Comments and reshares from personal accounts dramatically outperform company page posts in reach. The company page builds the brand; your personal profiles build the community.
The campaign arc I'd suggest for launch
The first thirty days should be a founding story campaign — why ARC exists, what the Appalachian corridor looks like in terms of cancer burden, what theranostics could do for patients who currently can't access it, and who you and James are. Tell the origin story in pieces across multiple posts rather than one long about section nobody reads.
Days thirty to ninety shift into education and engagement — the practical content pillars, starting to use polls ("What's the biggest barrier to theranostics adoption at your institution?"), asking questions that get comments from your target audience.
After ninety days you should have enough data from LinkedIn analytics to know what's resonating and double down.
The tactics that move the needle fastest for a new page
Getting your existing network to follow and engage in the first two weeks matters a lot because LinkedIn uses early engagement signals to decide how widely to distribute your content. A direct personal ask to colleagues, workshop attendees, and SNMMI connections to follow the page will accelerate this faster than any algorithmic strategy.
Tagging partner institutions — UT Medical Center, Carilion Clinic, ETSU — in relevant posts gets you in front of their follower bases. Tagging SNMMI when you post content relevant to their mission does the same.
LinkedIn newsletters are underused and get significantly better reach than regular posts right now. A monthly ARC newsletter distributed through LinkedIn covering theranostics adoption news in the region would build a subscriber base independently of your follower count.
The honest constraint
All of this requires consistent execution over six to twelve months before the compounding effect kicks in. The biggest risk for a small operation like ARC is starting strong and then going quiet when grant work gets busy. That's where the automated content pipeline we discussed earlier actually earns its value — having three weeks of posts queued and scheduled means the page stays active even when you're heads down on workshops.
Want me to draft the first month of posts as a content calendar you could start working from?
how to engage on linkedin but drive to website for blog posts, content, etc.
Mar 12
Synthesized LinkedIn engagement strategy to redirect audience toward content
Synthesized LinkedIn engagement strategy to redirect audience toward content
This is the right strategic instinct — LinkedIn builds the audience, your website owns the relationship. Here's how to do it effectively:
The fundamental LinkedIn constraint you need to know
LinkedIn's algorithm actively suppresses posts that contain external links because they want people to stay on LinkedIn. A post with a link in it will get roughly 50-70% less organic reach than a post without one. This is the core tension you're working around.
The workaround that actually works
The "link in comments" method is the most reliable approach. You post compelling content natively on LinkedIn — no link — and then in the first comment you post the link to the full article. Your post gets full algorithmic reach, and people who want more click through. It looks like this:
Post body: The full hook, enough value to stand alone, ending with "Full breakdown in the comments 👇"
First comment: "For the full post including the referral pathway framework we use at UT: [link]"
This consistently outperforms putting the link directly in the post.
The content bridge model
Think of each LinkedIn post as a trailer for the website content, not a summary of it. The post delivers genuine standalone value but leaves something unresolved that only the full article answers. For ARC specifically this might look like:
LinkedIn post: "We've seen three consistent barriers when community hospitals try to stand up their first Lu-177 program. The first one surprises most people — it's not regulatory, and it's not reimbursement."
Website: The full post covering all three barriers with actionable frameworks.
The LinkedIn post works on its own but creates enough curiosity that the motivated reader — exactly who you want — clicks through.
Content formats that drive clicks most effectively
Teasers with a clear "more at the link" hook work well but only if the LinkedIn content genuinely delivers partial value first. Nobody clicks "read our new blog post" but they do click when they've already gotten something useful and want the rest.
Carousels — LinkedIn's multi-image slide format — get strong organic reach and you can use the last slide as a CTA pointing to the website. A five-slide carousel on "What referring oncologists need to know about Lu-177 PSMA" with the final slide being "Download the full provider guide at arctheranostics.org" works well for your audience.
Polls are highly distributed by the algorithm and you can close the loop by posting the results with a link to a related article. "We asked 200 nuclear medicine professionals what their biggest theranostics barrier was. Here's what they said — and what the data tells us about solving it: [link]"
The email list is actually the real goal
LinkedIn followers are LinkedIn's asset, not yours. Website visitors you can convert to email subscribers are yours permanently regardless of what LinkedIn's algorithm does next year. Every piece of LinkedIn content should ultimately be working toward getting the right people onto your email list through the website. A simple lead magnet — a downloadable referral pathway template, a Lu-177 program readiness checklist, a community theranostics implementation guide — gives people a reason to hand over their email when they land on the site.
UTM parameters — don't skip this
Every link you post from LinkedIn to your website should have a UTM tag appended so you can see in Google Analytics exactly how much traffic LinkedIn is driving and which posts are most effective. A simple format like:
arctheranostics.org/blog/post-title?utm_source=linkedin&utm_medium=social&utm_campaign=blog
This takes thirty seconds to set up and tells you within ninety days which content pillars are actually driving your target audience to the site versus just getting LinkedIn engagement.
The content recycling loop
One piece of website content should generate multiple LinkedIn touchpoints rather than one post and done. A single blog post on referral barriers becomes a carousel, then a poll on the topic, then a comment engagement post sharing a reader response, then a podcast episode, then a LinkedIn newsletter entry — all pointing back to the original article. This is how small teams create the appearance of a robust content operation without burning out.
The practical setup on your Duda site
Make sure every blog post has a clear email capture — even just a "subscribe for updates" sidebar — and that social sharing buttons are visible. Add Open Graph meta tags to your posts so that when someone does share a link directly on LinkedIn it pulls a clean image and description rather than a blank preview. That alone meaningfully improves click-through on shared content.
Want me to map out a specific content recycling plan for one of your existing blog posts as a concrete example of how this loop works in practice?
how to add subscribe for updates on duda
Mar 12
Surveyed Duda's built-in email capture and subscription features
Surveyed Duda's built-in email capture and subscription features
Duda has a few native options and some third-party approaches — here's the practical breakdown:
Duda's Built-in Form Widget
The simplest path is Duda's native form widget. Drag it onto the page, strip it down to a single email field and a submit button, and connect it to Duda's built-in contact list. The limitation is that Duda's native form just stores submissions in your dashboard — it doesn't give you email marketing capability on its own. Fine for collecting emails, not fine for actually sending a newsletter.
The better approach — connect to an email platform
You want the form submissions flowing directly into an email marketing tool. The two most practical options for where ARC is right now:
Mailchimp has a native Duda integration. In Duda's App Market you can find the Mailchimp integration, connect your account, and any form submission automatically adds the subscriber to a list. Mailchimp's free tier handles up to 500 contacts which gets you started without cost.
Kit (formerly ConvertKit) is worth considering if the LinkedIn newsletter and content automation direction appeals to you — it's built more around creator and content workflows than Mailchimp's broadcast model.
Where to place the subscribe element
Several places work better than others for ARC specifically:
A persistent sidebar widget on every blog post page is the highest value placement — someone reading your content is already the right person to capture.
A footer subscription bar sitewide so it appears regardless of what page someone lands on.
A mid-post inline form after your first or second content section — not a popup, just an embedded "get posts like this in your inbox" form within the article flow. These convert well without being intrusive.
A dedicated landing page at something like arctheranostics.org/subscribe that you can point to directly from LinkedIn posts and your podcast show notes.
The lead magnet approach on Duda
Rather than just "subscribe for updates" — which has low conversion — pair the form with a content offer. On Duda you'd create a simple section with the offer described, the email form, and set up an automated confirmation email that delivers the download link. A "Community Theranostics Readiness Checklist" or "Lu-177 Referral Pathway Template" as a downloadable PDF would convert significantly better than a generic subscribe ask, and it immediately self-selects for your most engaged audience.
The actual Duda steps
Go to your page editor and add a new section where you want the form. Add the Form widget from the widget panel. In form settings, add a single field for email address, set the submit button text to something specific like "Send me the guide" rather than "Submit." Under form settings find the integrations tab and connect either Mailchimp or your chosen platform. Set up a thank you message or redirect to a thank you page.
For the sidebar specifically, Duda handles this through their column layout — you'd set your blog post template to a two-column layout with the subscribe form widget in the narrower right column.
One Duda-specific thing to check
Depending on your plan tier, some integrations and the ability to edit the blog post template layout may be restricted. If you hit a wall on the blog template specifically, the workaround is adding the form section manually to each post — tedious but functional until you're on a plan that supports template-level editing.
Want me to draft the copy for the subscribe section and the lead magnet offer so you have that ready when you set it up?
create 4 weeks of posts as you suggest for linked in
Mar 12
Orchestrated four weeks of LinkedIn content strategy
Orchestrated four weeks of LinkedIn content strategy
The full 4-week calendar is ready to download. Here's what's inside:
16 posts total — 4 per week structured across the pillars we discussed:
Week 1 — Founding story: What theranostics is, the Appalachian corridor data, meet Dustin and James, the Mars Shot grant announcement
Week 2 — Education hook: Referring physician barriers to Lu-177 PSMA, technologist workflow setup, a poll on implementation barriers, a case-based scenario for oncologists
Week 3 — Appalachia + behind the scenes: Community-first design philosophy, curriculum development in progress, cancer mortality data with narrative, podcast launch
Week 4 — Impact and CTA: Poll results follow-up, podcast episode amplification, workshop registration preview, campaign close and thank you
Every post includes the post body (no link, for algorithm reach), the first comment with the link placeholder, and notes on tagging, images, and resharing strategy.
There's also an appendix with a pre-posting checklist, UTM tag template, optimal posting times by day, and a 30-day analytics review guide.
A few things to do before you post: swap in live arctheranostics.org URLs with UTM tags, fill in the poll results on Post 13 once that closes, and line up James for personal reshares — his amplification on the technologist-facing posts especially will meaningfully extend the reach.
Arc linkedin calendar
Document · DOCX
create a referring provider overview for 177Lu-PSAM as described in week 2 post 5
Mar 16
Architected comprehensive provider guide covering patient criteria, referral pathways, and support resources
Architected comprehensive provider guide covering patient criteria, referral pathways, and support resources
Good content marketing — this resource is referenced in Post 5 and drives the click-through. I'll write it in your established blog voice and format it as a document you can post directly to the site or use as a downloadable lead magnet.
Assembled medical overview document for provider reference
Assembled medical overview document for provider reference
The guide is ready. Here's what's inside:
Structure follows your established blog voice — first-person, direct, self-aware, written for both a busy urologist and a motivated technologist without condescending to either.
Nine sections covering:
What theranostics actually is and how the PSMA mechanism works
Full VISION trial eligibility criteria in a color-coded table (green = include, red = watch carefully)
Direct answers to the three barriers from Post 5 — with the honest version of each answer, not the marketing version
A 6-step referral pathway in visual step boxes
What to tell your patient before the referral
A brief DOTATATE/NET parallel for endocrinologists who find the post
A documentation checklist table for smooth referrals
Common clinical questions (concurrent ADT, systemic therapy, earlier disease use, re-treatment)
A closing that loops back to the ARC workshop CTA
Two deployment options: post it as a long-form blog entry on arctheranostics.org, or convert it to PDF and use it as the lead magnet for your Duda subscribe form — "Download our referring provider guide to 177Lu-PSMA" is a strong conversion offer for the right audience.
A few places to personalize before publishing: the referral contact info section (once the ARC directory is live), and the closing question which I left open-ended for you to adjust based on what you want to drive in comments.
Arc 177lupsma referringproviderguide
Document · DOCX
should this be a blog post?
Mar 16
Weighed publishing formats and advocated hybrid blog-plus-download strategy
Weighed publishing formats and advocated hybrid blog-plus-download strategy
Honest answer: it's too long and too dense to work well as a standalone blog post, but it's almost perfect as a lead magnet PDF — which is actually more valuable strategically.
Here's why the distinction matters:
The blog post problem
That document is about 2,500 words with tables, clinical criteria, and a 6-step pathway. A reader landing on your blog from LinkedIn on their phone between clinic patients isn't going to read it linearly. They'll skim, lose the thread, and leave. Long-form clinical content that reads like a resource guide doesn't perform as blog content — it performs as something you download and refer back to.
What you actually want is both
A shorter blog post — 600 to 800 words — that covers the same territory at a higher level, written in your voice, ending with a CTA to download the full guide. The blog post is the trailer. The PDF is the film. The email capture happens at the handoff between the two.
That structure also gives Post 5 in the LinkedIn calendar its natural link destination: the blog post, not the PDF directly. Someone clicks through from LinkedIn, reads the post, decides they want the full referral guide, enters their email, gets the PDF. You've now converted a LinkedIn follower into an email subscriber who self-identified as a referring provider.
The PDF as a lead magnet also travels differently
A referring physician who downloads it can forward it to a colleague, print it for a department meeting, or keep it in a folder for when the right patient shows up. Blog posts don't behave that way.
Want me to write the companion blog post version — shorter, conversational, in your voice — that drives to the PDF download?
write companion blog post
Mar 16
Synthesized concise blog post companion piece
Synthesized concise blog post companion piece
The blog post is ready. A few things worth noting about how it's structured:
The title is designed to stop the scroll — "Your Patient Is Probably a Theranostics Candidate. Here's How to Know." speaks directly to the referring physician's self-interest without being clickbait. It implies the reader may already be missing something, which creates enough tension to read on.
It runs about 900 words — slightly above the 600-800 target but every section earns its place. You can trim the opening paragraph if it feels too long once you read it in your own voice.
The CTA box is embedded mid-page after the referral pathway section — not just at the bottom. Someone who's read far enough to understand the referral process is your highest-intent reader. That's where to capture them.
One thing to do before publishing: the closing question placeholder. I left it flagged with a suggested prompt — something like asking readers to drop their lingering theranostics question in the comments. That's the kind of thing that works better in your voice than mine, so I left it for you to write in.
The content flow between the three pieces now looks like this:
LinkedIn Post 5 → Blog post (trailer, ~900 words) → PDF guide download (full resource, gated by email)
Each layer serves the reader who wants to go deeper while capturing the ones who stop at each level. That's the architecture working the way it should.
Arc blogpost 177lupsma referringprovider
Document · DOCX
create a guide on getting started with 177LU therapies
Mar 16
Deliberated on awaiting user input before proceeding
Deliberated on awaiting user input before proceeding
Before I build this, one framing question — because it changes the document significantly:
Take a second to answer those two questions and I'll build the right document. The audience question especially matters — the technologist version reads like an operations manual, the physician/admin version reads more like a program launch decision framework with business case language. Getting that wrong means the guide lands with the wrong person or speaks past the right one.
make this in to a blog post
Mar 16
Resolved ambiguity and charted blog post strategy independently
Resolved ambiguity and charted blog post strategy independently
Got it — I'll write it directly as a blog post in your voice, targeting the broadest useful audience (community hospital NM professionals and program leaders), and covering the key getting-started themes at blog depth rather than guide depth. Same structure as the PSMA companion post — conversational, bolded section headers, closing question placeholder, CTA for a future full guide.
Ran 2 commands, created a file, read a file
Ran 2 commands, created a file, read a file
The blog post is ready. Here's how it's structured:
Six sections, roughly 1,200 words — slightly longer than the PSMA companion post because the implementation audience needs more context to find it credible. Each section earns its length.
The six sections are role clarity as the hidden trip wire, regulatory demystified, facility requirements without the vendor spin, radiopharmacy logistics as the scheduling backbone, the case for dosimetry investment, and reimbursement with honest nuance.
The voice is consistent with your established pattern — first person, direct, self-aware about being a physicist rather than a clinician, willing to say what vendors and regulators won't say plainly.
A few things worth noting before you publish:
The title is deliberately provocative — "what no one tells you up front" sets up a promise the post has to keep, and I think it does. If that framing feels too informal for your taste, an alternative is "Starting a 177Lu Program at a Community Hospital: What to Map Out Before Your First Patient."
The dosimetry section takes a clear position because you have one. If you want to soften the "programs that cut corners" framing slightly, that's easy to adjust — but I'd encourage leaving the substance intact.
The content architecture for this topic now looks like:
Blog post (this) → Full implementation guide PDF (still to build, now with a clear audience and scope informed by the blog) → Workshop as the live experience
That CTA box points to a guide that doesn't exist yet — worth building that next if this post is going live soon.
Arc blogpost gettingstarted 177lu
Document · DOCX
for this linkedin post, write an ARC website blog ahtat covers full workflow and role structure in community Lu-177 setting
For nuclear medicine technologists thinking about Lu-177 therapy programs at their institution:
The biggest operational question we hear isn't dosimetry. It isn't even regulatory.
It's: 'Who handles what, and how do we set up the workflow so nobody is doing something outside their scope?'
The short answer is that a functional Lu-177 program at a community hospital requires clarity across at least five roles before the first patient is treated:
— Nuclear medicine physician (therapy planning, dose prescription)
— Nuclear pharmacist or authorized user (radiopharmaceutical receipt and preparation)
— Nuclear medicine technologist (administration, imaging, patient monitoring)
— Medical physicist (dosimetry, radiation safety program)
— Referring provider (patient selection, follow-up coordination)
The challenge in community settings is that some of these roles may overlap, be unfilled, or require new credentialing. That's not a dealbreaker — but it has to be mapped out explicitly before you start.
Which of these roles is the hardest to fill or define at your institution? Genuinely curious.
Show more
3:28 PM
Synthesized LinkedIn content into comprehensive blog framework
Synthesized LinkedIn content into comprehensive blog framework
The blog post is ready. It's the most substantial piece in the ARC content library so far — appropriately, because the audience (NM technologists and program builders) will read deeply if the content earns it, and this does.
What's inside:
The first half covers the five core roles with a visual card for each — what the role owns, and a specific "in community settings, watch for" callout that flags the real-world gaps that trip programs up. The authorized user credential timing issue, the nuclear pharmacist ambiguity with commercial pharmacy partners, the physicist scope mismatch, the referring provider communication breakdown — all named plainly.
The second half walks the full 10-step patient workflow from referral receipt through post-therapy follow-up, with the role owner identified at each step and the specific failure modes called out. Steps 3 (pharmacy scheduling), 6 (administration protocol), and 10 (response assessment handoff) get the most detailed treatment because that's where community programs tend to have the most undocumented assumptions.
The closing question loops back explicitly to the LinkedIn post — "I asked this on LinkedIn and got honest answers, curious whether the blog audience matches" — which is a nice connective tissue move between channels.
The CTA points to a role mapping worksheet, which you don't have yet but should build — it's the natural lead magnet for this post, a more operationally useful download than a general guide. One page, table format, every workflow step with a blank "owner" column. That's a morning's work and a strong email capture offer for the NM professional audience.
The content stack for this topic now looks like:
LinkedIn Post 6 → This blog post → Role mapping worksheet (to build) → Workshop as live application
Arc blogpost workflowroles lu177
Document · DOCX
provide 5 title suggestions for this blog post and create a representative banner image that highlights the high level concept of the blog post
3:59 PM
Architected branded banner showcasing five interconnected clinical workflow roles
Architected branded banner showcasing five interconnected clinical workflow roles
Five title options:
Who Does What: Mapping Roles and Workflow for a Community Lu-177 Program (current — clear, direct, searchable)
The Five Roles Your Lu-177 Program Can't Launch Without (list-forward, high click potential)
Before the First Patient: A Community Hospital Lu-177 Workflow Guide (timeline framing, speaks to planners)
Nobody Hands You the Map: Building Role Clarity for Community Lu-177 Programs (callbacks to the blog voice, more editorial)
Scope, Sequence, and Ownership: The Operational Blueprint for Community Lu-177 Therapy (professional/administrative audience, more formal)
My recommendation is option 2 for the blog post title and option 1 as the SEO meta title — they serve different jobs.
Now for the banner:
The banner uses ARC's deep blue as the base, with each of the five roles color-coded distinctly — green for the referring provider, blue for the NM physician, purple for the nuclear pharmacist, teal for the NM technologist, and amber for the medical physicist. The numbered step badges and connecting arrows reinforce the workflow concept, and the faint atomic orbit rings in the background tie it visually to the nuclear medicine context without being heavy-handed.
Recommended title pairing with this banner:
Option 2 — "The Five Roles Your Lu-177 Program Can't Launch Without" — works best with this visual since the banner literally shows five numbered roles. The image and the headline tell the same story.
To export for Duda: right-click the banner → Save as SVG, or I can generate it as a PNG-ready file. Let me know which format Duda needs and I'll produce the file version.
make this as an html as duda won't let me format that in a nice way
Role 1 — Nuclear Medicine Physician / Authorized User
Owns:
• Patient evaluation and therapy eligibility determination
• Dose prescription — written directive for each treatment cycle
• Review of dosimetry data and therapy modification decisions
• Medical oversight of the radiation safety program for therapeutic use
• Consent process and patient and family education on radiation precautions
In community settings, watch for:
The authorized user designation is a specific NRC/Agreement State credential that not every nuclear medicine physician holds. Your physician may be authorized for diagnostic procedures but not therapeutic use of Lu-177 specifically. Verify this early — adding an authorized user to a radioactive materials license takes time, and your program cannot treat patients until it is done.
Show more
4:08 PM
Identified and corrected misaligned role titles across cards
Identified and corrected misaligned role titles across cards
The role titles got misaligned. Let me fix that with str_replace.
Edited 4 files, ran a command
Edited 4 files, ran a command
Here's a preview of how it renders:
Presented file
Presented file
The HTML file is ready to download. Here's how to drop it into Duda:
In your Duda editor, add an HTML widget (under the "Other" or "Advanced" widget category) to your blog post page. Open the widget, paste the full contents of this file, and save. It will render the accordion cards exactly as shown in the preview.
A few things worth knowing about the implementation:
Each card is collapsed by default with an expand/collapse toggle, so the page doesn't feel overwhelming on load. The "Expand all / Collapse all" button at the top handles bulk toggling. Each role has its color-coded left border and numbered badge matching the banner image, so the visual language is consistent if you use both on the same page. The fonts pull from Google Fonts (Source Serif 4 and DM Sans) — if Duda strips external font calls, it will gracefully fall back to Georgia and system sans-serif, which still looks clean.
If Duda's HTML widget has trouble with the Google Fonts tag in the , just remove those two lines and the fallback fonts will take over automatically.
Arc role cards
Code · HTML
integrate the role cards into this html after the paragraph "At an academic center these roles map cleanly to five or more different people with clearly defined scope. At a community hospital they may overlap, be split across part-time staff, or require building a new relationship with an outside partner. None of that is disqualifying — but every gap has to be explicitly addressed before you treat your first patient, not discovered during it."
Show more
4:13 PM
Strategized HTML integration point and output formatting
Strategized HTML integration point and output formatting
Ready to paste directly into Duda. A few things worth noting about how this is integrated:
All CSS class names are prefixed with arc- — so nothing conflicts with Duda's own stylesheet or any other classes on the page. This was the main risk with the previous standalone version.
The JavaScript uses Array.prototype syntax rather than spread operators or arrow functions, which improves compatibility with any older browser polyfills Duda might be running under the hood.
The
1
Role 1Nuclear Medicine Physician / Authorized User
Owns
Patient evaluation and therapy eligibility determination
Dose prescription — written directive for each treatment cycle
Review of dosimetry data and therapy modification decisions
Medical oversight of the radiation safety program for therapeutic use
Consent process and patient and family education on radiation precautions
In community settings, watch for
The authorized user designation is a specific NRC/Agreement State credential that not every nuclear medicine physician holds. Your physician may be authorized for diagnostic procedures but not therapeutic use of Lu-177 specifically. Verify this early — adding an authorized user to a radioactive materials license takes time, and your program cannot treat patients until it is done.
2
Role 2Nuclear Pharmacist / Authorized Nuclear Pharmacist
Owns
Receipt and inspection of the Lu-177 dose shipment from the commercial pharmacy
Documentation of receipt, activity measurement, and chain of custody
Preparation of the dose for administration (drawing up, labeling, transfer to shielded syringe)
Quality control checks before release for patient administration
Radioactive waste management and documentation
In community settings, watch for
Most community hospitals do not have an in-house nuclear pharmacist for therapeutic work. The commercial radiopharmacy that supplies your Lu-177 may handle preparation and delivery of a patient-ready dose — but receipt, documentation, and waste on your end still require a qualified person. Clarify with your pharmacy partner exactly what arrives ready-to-administer versus what requires on-site handling, and make sure you have the credentialed staff to cover what’s your responsibility.
3
Role 3Nuclear Medicine Technologist
Owns
IV access establishment and pre-administration patient assessment
Radiopharmaceutical administration under physician supervision
Patient monitoring during and immediately after infusion
Post-therapy imaging (SPECT/CT for dosimetry or response assessment)
Radiation safety instruction delivery to patient and family before discharge
Documentation of administration, patient response, and any adverse events
In community settings, watch for
The technologist is closest to the patient on treatment day — which means they need the clearest understanding of what they own and what requires physician involvement. Protocols for handling infusion reactions, extravasation, and patient distress need to be written, practiced, and immediately accessible on treatment day. This role also carries the highest radiation exposure potential for staff — ALARA practices, dosimetry badge use, and shielding protocols are non-negotiable and require documented training.
4
Role 4Medical Physicist
Owns
Radiation safety program development and maintenance
Facility shielding assessment and room qualification
Staff dosimetry monitoring program and exposure tracking
Dosimetry calculations for therapy patients (absorbed dose to tumor and organs at risk)
Quality assurance for imaging systems used in therapy assessment
Survey and release calculations for patient discharge under 10 CFR 35.75
Radioactive waste program oversight
In community settings, watch for
This is the role most commonly underfunded or assumed to be covered without explicit confirmation. A part-time physicist who covers diagnostic QC is not automatically prepared to run a therapeutic radiation safety program — the scope is different. Dosimetry for Lu-177 specifically requires SPECT/CT quantification capability and familiarity with dosimetry platforms. If your physicist doesn’t have this background, budget for training or bring in a consultant for program setup. This is not the place to wing it.
5
Role 5Referring Provider
Owns
Patient identification and initial eligibility screening
PSMA-PET/CT ordering and results review
Coordination of pre-therapy labs and medical optimization
Ongoing oncologic management during the treatment course
PSA and response monitoring between cycles
Long-term follow-up and survivorship care
In community settings, watch for
The referring provider is not inside your department — but they are inside your workflow. The most common breakdown in community programs isn’t on treatment day; it’s in the coordination handoffs before and after. A pre-treatment checklist shared with referring providers, a defined communication protocol for between-cycle updates, and a clear escalation path for clinical concerns that arise between visits will save you significant friction. Build the referring provider relationship before your first patient, not during.
Show more
4:13 PM
Strategized HTML integration point and output formatting
Strategized HTML integration point and output formatting
Ready to paste directly into Duda. A few things worth noting about how this is integrated:
All CSS class names are prefixed with arc- — so nothing conflicts with Duda's own stylesheet or any other classes on the page. This was the main risk with the previous standalone version.
The JavaScript uses Array.prototype syntax rather than spread operators or arrow functions, which improves compatibility with any older browser polyfills Duda might be running under the hood.
The
1
Role 1Nuclear Medicine Physician / Authorized User
Owns
Patient evaluation and therapy eligibility determination
Dose prescription — written directive for each treatment cycle
Review of dosimetry data and therapy modification decisions
Medical oversight of the radiation safety program for therapeutic use
Consent process and patient and family education on radiation precautions
In community settings, watch for
The authorized user designation is a specific NRC/Agreement State credential that not every nuclear medicine physician holds. Your physician may be authorized for diagnostic procedures but not therapeutic use of Lu-177 specifically. Verify this early — adding an authorized user to a radioactive materials license takes time, and your program cannot treat patients until it is done.
2
Role 2Nuclear Pharmacist / Authorized Nuclear Pharmacist
Owns
Receipt and inspection of the Lu-177 dose shipment from the commercial pharmacy
Documentation of receipt, activity measurement, and chain of custody
Preparation of the dose for administration (drawing up, labeling, transfer to shielded syringe)
Quality control checks before release for patient administration
Radioactive waste management and documentation
In community settings, watch for
Most community hospitals do not have an in-house nuclear pharmacist for therapeutic work. The commercial radiopharmacy that supplies your Lu-177 may handle preparation and delivery of a patient-ready dose — but receipt, documentation, and waste on your end still require a qualified person. Clarify with your pharmacy partner exactly what arrives ready-to-administer versus what requires on-site handling, and make sure you have the credentialed staff to cover what’s your responsibility.
3
Role 3Nuclear Medicine Technologist
Owns
IV access establishment and pre-administration patient assessment
Radiopharmaceutical administration under physician supervision
Patient monitoring during and immediately after infusion
Post-therapy imaging (SPECT/CT for dosimetry or response assessment)
Radiation safety instruction delivery to patient and family before discharge
Documentation of administration, patient response, and any adverse events
In community settings, watch for
The technologist is closest to the patient on treatment day — which means they need the clearest understanding of what they own and what requires physician involvement. Protocols for handling infusion reactions, extravasation, and patient distress need to be written, practiced, and immediately accessible on treatment day. This role also carries the highest radiation exposure potential for staff — ALARA practices, dosimetry badge use, and shielding protocols are non-negotiable and require documented training.
4
Role 4Medical Physicist
Owns
Radiation safety program development and maintenance
Facility shielding assessment and room qualification
Staff dosimetry monitoring program and exposure tracking
Dosimetry calculations for therapy patients (absorbed dose to tumor and organs at risk)
Quality assurance for imaging systems used in therapy assessment
Survey and release calculations for patient discharge under 10 CFR 35.75
Radioactive waste program oversight
In community settings, watch for
This is the role most commonly underfunded or assumed to be covered without explicit confirmation. A part-time physicist who covers diagnostic QC is not automatically prepared to run a therapeutic radiation safety program — the scope is different. Dosimetry for Lu-177 specifically requires SPECT/CT quantification capability and familiarity with dosimetry platforms. If your physicist doesn’t have this background, budget for training or bring in a consultant for program setup. This is not the place to wing it.
5
Role 5Referring Provider
Owns
Patient identification and initial eligibility screening
PSMA-PET/CT ordering and results review
Coordination of pre-therapy labs and medical optimization
Ongoing oncologic management during the treatment course
PSA and response monitoring between cycles
Long-term follow-up and survivorship care
In community settings, watch for
The referring provider is not inside your department — but they are inside your workflow. The most common breakdown in community programs isn’t on treatment day; it’s in the coordination handoffs before and after. A pre-treatment checklist shared with referring providers, a defined communication protocol for between-cycle updates, and a clear escalation path for clinical concerns that arise between visits will save you significant friction. Build the referring provider relationship before your first patient, not during.
Show more
4:13 PM
Strategized HTML integration point and output formatting
Strategized HTML integration point and output formatting
Ready to paste directly into Duda. A few things worth noting about how this is integrated:
All CSS class names are prefixed with arc- — so nothing conflicts with Duda's own stylesheet or any other classes on the page. This was the main risk with the previous standalone version.
The JavaScript uses Array.prototype syntax rather than spread operators or arrow functions, which improves compatibility with any older browser polyfills Duda might be running under the hood.
The
1
Role 1Nuclear Medicine Physician / Authorized User
Owns
Patient evaluation and therapy eligibility determination
Dose prescription — written directive for each treatment cycle
Review of dosimetry data and therapy modification decisions
Medical oversight of the radiation safety program for therapeutic use
Consent process and patient and family education on radiation precautions
In community settings, watch for
The authorized user designation is a specific NRC/Agreement State credential that not every nuclear medicine physician holds. Your physician may be authorized for diagnostic procedures but not therapeutic use of Lu-177 specifically. Verify this early — adding an authorized user to a radioactive materials license takes time, and your program cannot treat patients until it is done.
2
Role 2Nuclear Pharmacist / Authorized Nuclear Pharmacist
Owns
Receipt and inspection of the Lu-177 dose shipment from the commercial pharmacy
Documentation of receipt, activity measurement, and chain of custody
Preparation of the dose for administration (drawing up, labeling, transfer to shielded syringe)
Quality control checks before release for patient administration
Radioactive waste management and documentation
In community settings, watch for
Most community hospitals do not have an in-house nuclear pharmacist for therapeutic work. The commercial radiopharmacy that supplies your Lu-177 may handle preparation and delivery of a patient-ready dose — but receipt, documentation, and waste on your end still require a qualified person. Clarify with your pharmacy partner exactly what arrives ready-to-administer versus what requires on-site handling, and make sure you have the credentialed staff to cover what’s your responsibility.
3
Role 3Nuclear Medicine Technologist
Owns
IV access establishment and pre-administration patient assessment
Radiopharmaceutical administration under physician supervision
Patient monitoring during and immediately after infusion
Post-therapy imaging (SPECT/CT for dosimetry or response assessment)
Radiation safety instruction delivery to patient and family before discharge
Documentation of administration, patient response, and any adverse events
In community settings, watch for
The technologist is closest to the patient on treatment day — which means they need the clearest understanding of what they own and what requires physician involvement. Protocols for handling infusion reactions, extravasation, and patient distress need to be written, practiced, and immediately accessible on treatment day. This role also carries the highest radiation exposure potential for staff — ALARA practices, dosimetry badge use, and shielding protocols are non-negotiable and require documented training.
4
Role 4Medical Physicist
Owns
Radiation safety program development and maintenance
Facility shielding assessment and room qualification
Staff dosimetry monitoring program and exposure tracking
Dosimetry calculations for therapy patients (absorbed dose to tumor and organs at risk)
Quality assurance for imaging systems used in therapy assessment
Survey and release calculations for patient discharge under 10 CFR 35.75
Radioactive waste program oversight
In community settings, watch for
This is the role most commonly underfunded or assumed to be covered without explicit confirmation. A part-time physicist who covers diagnostic QC is not automatically prepared to run a therapeutic radiation safety program — the scope is different. Dosimetry for Lu-177 specifically requires SPECT/CT quantification capability and familiarity with dosimetry platforms. If your physicist doesn’t have this background, budget for training or bring in a consultant for program setup. This is not the place to wing it.
5
Role 5Referring Provider
Owns
Patient identification and initial eligibility screening
PSMA-PET/CT ordering and results review
Coordination of pre-therapy labs and medical optimization
Ongoing oncologic management during the treatment course
PSA and response monitoring between cycles
Long-term follow-up and survivorship care
In community settings, watch for
The referring provider is not inside your department — but they are inside your workflow. The most common breakdown in community programs isn’t on treatment day; it’s in the coordination handoffs before and after. A pre-treatment checklist shared with referring providers, a defined communication protocol for between-cycle updates, and a clear escalation path for clinical concerns that arise between visits will save you significant friction. Build the referring provider relationship before your first patient, not during.
Understanding the key players and their roles within a theranostic environment is critical to a successful program.
When I talk to centers interested in developing theranostic programs, their biggest concern is almost never dosimetry. It’s almost never regulatory paperwork. Those things certainly come up, but they’re not the primary driver of hesitation in starting a program.
The thing that keeps people up at night is staffing and infrastructure. Perhaps their setup is that they have two technologists, a part-time physicist, a nuclear pharmacist 40 minutes away, and a nuclear medicine physician who also reads diagnostic studies. Who does what? Who owns what? And what happens if someone does something they’re not supposed to, or doesn’t do something they were supposed to, and nobody finds out until a patient is already in the chair?
That’s not an irrational fear. It’s the right question. And the honest answer is that a radionculide therapy program without explicitly defined roles isn’t a program, it’s a liability waiting to happen.
This post maps the core roles a functional community Lu-177 program should understand and for which clear responsibilities should be defined.
Lu-177 Program Roles
The five roles every community Lu-177 program needs
A functional program requires understanding of these five roles before the first patient is treated. In community settings, some roles may overlap or require new credentialing and that's not a dealbreaker, but every gap has to be addressed in advance.
1
Role 1
Nuclear Medicine Physician / Authorized User
Owns
Patient evaluation and therapy eligibility determination
Dose prescription — written directive for each treatment cycle
Review of dosimetry data and therapy modification decisions
Medical oversight of the radiation safety program for therapeutic use
Consent process and patient and family education on radiation precautions
In community settings, watch for
The authorized user designation for parenteral administration of radioactive byproduct material requiring a writtend directive, is a specific NRC/Agreement State credential that not every nuclear medicine physician or radiation oncologist holds. Your physician may be authorized for diagnostic procedures but not therapeutic use of Lu-177 specifically. Verify this early as adding an authorized user to a radioactive materials license takes time, and your program cannot treat patients until it is done. NRC 10 CFR 35.396
Receipt and inspection of the Lu-177 dose shipment from the commercial pharmacy
Documentation of receipt, activity measurement, and chain of custody
Preparation of the dose for administration (drawing up, labeling, transfer to shielded syringe)
Quality control checks before release for patient administration
Radioactive waste management and documentation
In community settings, watch for
Most community hospitals do not have an in-house nuclear pharmacist for therapeutic work. The commercial radiopharmacy that supplies your Lu-177 may handle preparation and delivery of a patient-ready dose, but receipt, documentation, and waste on your end still require a qualified person. Clarify with your pharmacy partner exactly what arrives ready-to-administer versus what requires on-site handling that may fall under USP 825 which describes appropriate methods for preparation, compounding, dispensing, and repackaging of radiopharmaceuticals.
3
Role 3
Nuclear Medicine Technologist
Owns
IV access establishment and pre-administration patient assessment
Radiopharmaceutical administration under physician supervision
Patient monitoring during and immediately after infusion
Post-therapy imaging (SPECT/CT for dosimetry or response assessment)
Radiation safety instruction delivery to patient and family before discharge
Documentation of administration, patient response, and any adverse events
In community settings, watch for
The technologist is typically the closest to the patient on treatment day, which means they need the clearest understanding of what processes they own and what requires physician involvement. Protocols for handling infusion reactions, extravasation, and patient distress need to be written, practiced, and immediately accessible on treatment day. This role also carries the highest radiation exposure potential for staff, however, if routine precautions are followed, the radiation exposure to staff is well within safety guidelines.
4
Role 4
Medical Physicist
Owns
Radiation safety program development and maintenance
Facility shielding assessment and room qualification
Staff dosimetry monitoring program and exposure tracking
Dosimetry calculations for therapy patients (absorbed dose to tumor and organs at risk)
Quality assurance for imaging systems used in therapy assessment
Survey and release calculations for patient discharge under 10 CFR 35.75
Radioactive waste program oversight
In community settings, watch for
This is the role most commonly underfunded or assumed to be covered without explicit confirmation. A part-time physicist who covers diagnostic QC is not automatically prepared to run a therapeutic radiation safety program where the scope is considerably different. Dosimetry for Lu-177 specifically requires SPECT/CT quantification capability and familiarity with dosimetry platforms. If your physicist doesn't have this background, budget for training or bring in a consultant for program setup to mitigate potential startup issues and risk.
5
Role 5
Referring Provider
Owns
Patient identification and initial eligibility screening
PSMA and DOTATATE-PET/CT ordering and results review
Coordination of pre-therapy labs and medical optimization
Ongoing oncologic management during the treatment course
PSA, chromogranin-A, and other response monitoring between cycles
Long-term follow-up and survivorship care
In community settings, watch for
The referring provider is not likely inside your department, but they are a critical part of your workflow. The most common breakdown in community programs isn't on treatment day; it's in the coordination handoffs before and after. A pre-treatment checklist shared with referring providers, a defined communication protocol for between-cycle updates, and a clear escalation path for clinical concerns will save significant friction. Build this relationship before your first patient and grow the rapport with the physicians and their staff.
The goal of this exercise isn't paperwork. It's making sure that on the day your first patient sits down for treatment, every person in the room knows exactly what they are responsible for and that nobody is improvising. If you want to work through this with a team that has done it, that's exactly what ARC's regional workshops are designed for. Registration is open now for our April 18th, 2026 workshop. Just navigate to our workshops page to register.
As we celebrate World Theranostics Day and the amazing developments in this field, it is good to remember how access impacts populations not only from East Tennessee to Southwest Virginia, but around the world.
Determining whether your patient is an appropriate candidate for currently available radiopharmaceutical therapies can be challenging. This guide helps demystify the process.
You’ve chosen a terrific way of integrating images and text into your website. Move the image anywhere you want in this container and the text will automatically wrap around it. You can display events team members new products and more easily and creatively. To start add an image from the Image Picker and edit it as you would edit any image in the system. For example you can link the image to existing pages in your site a website URL a popup or an anchor. After you’ve chosen the image add your text. You can add text that describes the image you’ve selected or simply use the image for decorative purposes. \nYou’ve chosen a terrific way of integrating images and text into your website. Move the image anywhere you want in this container and the text will automatically wrap around it. You can display events team members new products more easily and creatively. To start add an image from the Image Picker and edit it as you would edit any image in the system. For example you can link the image to existing pages in your site a website URL a popup or an anchor. After you’ve chosen the image add your text. You can add text that describes the image you’ve selected or simply use the image for decorative purposes.